var title_f32_9_32912="Diverticular abscess CT";
var content_f32_9_32912=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diverticular abscess of the sigmoid colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 362px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single axial CT scan of the pelvis demonstrates an abscess surrounding and compressing the sigmoid colon (large arrow) which is markedly narrowed. There is a small amount of gas within the abscess (arrowhead).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Norman Joffe, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32912=[""].join("\n");
var outline_f32_9_32912=null;
var title_f32_9_32913="Patient information: Acute compartment syndrome (The Basics)";
var content_f32_9_32913=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?10/51/11058\">",
"         Patient information: Cast and splint care (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?29/34/30243\">",
"         Patient information: Fractures (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?21/59/22450\">",
"         Patient information: Rhabdomyolysis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/43/25266\">",
"         Patient information: Skin burns (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?31/55/32625\">",
"         Patient information: Skin burns (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Acute compartment syndrome (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/acute-compartment-syndrome-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H10844176\">",
"      <span class=\"h1\">",
"       What is acute compartment syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Acute compartment syndrome, or &ldquo;ACS&rdquo; for short, is a condition that causes severe muscle pain. It is an emergency that needs to be treated quickly.",
"     </p>",
"     <p>",
"      A &ldquo;compartment&rdquo; is a group of muscles. Each muscle compartment in the body is surrounded by a strong band of tissue, called &ldquo;fascia.&rdquo; In ACS, too much pressure builds up in a muscle compartment. This is usually caused by bleeding or a collection of fluid. The abnormal build-up of pressure damages the muscles and causes symptoms. ACS happens quickly, usually over a few hours. (The word &ldquo;acute&rdquo; means that something happens quickly.)",
"     </p>",
"     <p>",
"      ACS most commonly happens in the forearm or lower leg (calf). But it can also happen in the foot, upper leg, or buttock.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10844191\">",
"      <span class=\"h1\">",
"       What causes acute compartment syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Different things can cause ACS. Most often, it happens after an injury, such as a broken bone or severe burn. But it can also happen if a cast or bandage is put on too tight.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10844326\">",
"      <span class=\"h1\">",
"       What are the symptoms of acute compartment syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms of ACS usually get worse quickly (over a few hours) and include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain that is much worse than expected, given the injury",
"       </li>",
"       <li>",
"        A deep ache or burning pain that doesn&rsquo;t go away",
"       </li>",
"       <li>",
"        Numbness, tingling, or loss of feeling",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If ACS isn&rsquo;t treated right away, it can cause other symptoms. These include muscle weakness or being unable to move certain muscles.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10844206\">",
"      <span class=\"h1\">",
"       Is there a test for acute compartment syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor will ask about your symptoms and do an exam. Doctors usually do repeat exams over time to see if your symptoms change or get worse.",
"     </p>",
"     <p>",
"      The only way your doctor can know for sure if you have ACS is to check the pressure in your muscle compartment. Doctors can use different devices to measure this pressure. But in general, this test involves putting a thin needle or tube into your muscle.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10844221\">",
"      <span class=\"h1\">",
"       How is acute compartment syndrome treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main treatment for ACS is a type of surgery called a &ldquo;fasciotomy.&rdquo; During this surgery, the doctor will cut open the fascia and muscles to relieve the abnormal build-up of pressure in the compartment.",
"     </p>",
"     <p>",
"      After surgery, the doctor won&rsquo;t close the cut right away. Instead, he or she will leave the cut open and bandage it loosely. The doctor will do another surgery, usually a few days later, to close the cut.",
"     </p>",
"     <p>",
"      If ACS isn&rsquo;t treated quickly enough, muscles can die. Then people might need surgery to remove the injured body part, called &ldquo;amputation.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10844236\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/59/22450?source=see_link\">",
"       Patient information: Rhabdomyolysis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/43/25266?source=see_link\">",
"       Patient information: Skin burns (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/34/30243?source=see_link\">",
"       Patient information: Fractures (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/51/11058?source=see_link\">",
"       Patient information: Cast and splint care (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/55/32625?source=see_link\">",
"       Patient information: Skin burns (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/9/32913?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 82808 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-E9F4F161E5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32913=[""].join("\n");
var outline_f32_9_32913=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10844176\">",
"      What is acute compartment syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10844191\">",
"      What causes acute compartment syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10844326\">",
"      What are the symptoms of acute compartment syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10844206\">",
"      Is there a test for acute compartment syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10844221\">",
"      How is acute compartment syndrome treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10844236\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/51/11058?source=related_link\">",
"      Patient information: Cast and splint care (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/34/30243?source=related_link\">",
"      Patient information: Fractures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/59/22450?source=related_link\">",
"      Patient information: Rhabdomyolysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/55/32625?source=related_link\">",
"      Patient information: Skin burns (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/43/25266?source=related_link\">",
"      Patient information: Skin burns (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_9_32914="Symptoms of hypermagnesemia";
var content_f32_9_32914=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Symptoms of hypermagnesemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32914/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32914/contributors\">",
"     Zalman S Agus, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32914/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32914/contributors\">",
"     Stanley Goldfarb, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32914/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32914/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/9/32914/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypermagnesemia is an uncommon problem in the absence of magnesium administration or renal failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/58/13220?source=see_link\">",
"     \"Causes and treatment of hypermagnesemia\"",
"    </a>",
"    .) When it occurs, the elevation in the plasma magnesium concentration is usually mild (&lt;3",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    3.6",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    or 1.5",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and the patient is asymptomatic. However, three types of symptoms may be seen when the plasma magnesium concentration exceeds 4",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (4.8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 2",
"    <span class=\"nowrap\">",
"     mmol/L):",
"    </span>",
"    neuromuscular; cardiovascular; and hypocalcemia. The approximate relation between clinical manifestations and the degree of hypermagnesemia can be summarized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plasma magnesium concentration 4 to 6",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (4.8 to 7.2",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 2 to 3",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      &ndash; nausea, flushing, headache, lethargy, drowsiness, and diminished deep tendon reflexes.",
"     </li>",
"     <li>",
"      Plasma magnesium concentration 6 to 10",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (7.2 to 12",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 3 to 5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      &ndash; somnolence, hypocalcemia, absent deep tendon reflexes, hypotension, bradycardia, and ECG changes.",
"     </li>",
"     <li>",
"      Plasma magnesium concentration above 10",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (12",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      &ndash; muscle paralysis, respiratory paralysis, complete heart block, and cardiac arrest. In most cases, respiratory failure precedes cardiac collapse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NEUROMUSCULAR EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuromuscular toxicity is the most consistently observed complication of hypermagnesemia. Increased magnesium decreases impulse transmission across the neuromuscular junction producing a curare-like effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The initial clinical manifestation of this problem is diminished deep tendon reflexes that is usually first noted when the plasma magnesium concentration reaches 4 to 6",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (4.8 to 7.2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 2 to 3",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    More severe hypermagnesemia can result in somnolence, loss of deep tendon reflexes, and muscle paralysis, potentially leading to flaccid quadriplegia and, since smooth muscle function is also impaired, decreased respiration and eventual apnea. Parasympathetic blockade inducing fixed and dilated pupils, thereby mimicking a central brain&ndash;stem herniation syndrome, can also be seen in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnesium is an effective calcium channel blocker both extracellularly and intracellularly; in addition, intracellular magnesium profoundly blocks several cardiac potassium channels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/1\">",
"     1",
"    </a>",
"    ]. These changes can combine to impair cardiovascular function. Bradycardia and hypotension begin to appear at a plasma magnesium concentration above 4 to 5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (4.8 to 6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 2 to 2.5",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/1\">",
"     1",
"    </a>",
"    ]. A variety of ECG changes can be seen at a concentration of 5 to 10",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (6 to 12",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 2.5 to 5",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    including prolongation of the P-R interval, an increase in QRS duration, and an increase in Q-T interval. Complete heart block and cardiac arrest may occur at a plasma magnesium concentration above 15",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (18",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 7.5",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     HYPOCALCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moderate",
"    hypermagnesemia can inhibit the secretion of parathyroid hormone, leading to a reduction in the plasma calcium concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/4\">",
"     4",
"    </a>",
"    ]. This effect has been described after magnesium infusion in normal subjects and in pregnant women with eclampsia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. The fall in the plasma calcium concentration is usually transient and produces no symptoms; in some cases, however, ECG abnormalities associated with hypocalcemia can be seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     OTHER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypermagnesemia may be associated with non-specific symptoms such as nausea, vomiting, and flushing. In addition, hyperkalemia has been described in three pregnant women following parenteral magnesium administration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The frequency of this complication is uncertain, since the plasma potassium concentration is not routinely monitored in this setting. The mechanism responsible for the hyperkalemia is unclear, but decreased urinary potassium excretion due to magnesium-induced blockade of renal potassium channels may be involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32914/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Side effects associated with the use of magnesium in pregnant women are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link&amp;anchor=H23#H23\">",
"     \"Preeclampsia: Management and prognosis\", section on 'Complications and side effects'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/53/35674?source=see_link&amp;anchor=H18#H18\">",
"     \"Inhibition of acute preterm labor\", section on 'Maternal and fetal side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25337260\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neuromuscular toxicity is the most common complication of hypermagnesemia. Symptoms range from diminished deep tendon reflexes when the plasma magnesium concentration reaches 4 to 6",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (4.8 to 7.2",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 2 to 3",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      to somnolence, loss of deep tendon reflexes, and muscle paralysis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Neuromuscular effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bradycardia and hypotension may occur at a plasma magnesium concentration above 4 to 5",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (4.8 to 6",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 2 to 2.5",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      Observed electrocardiogram changes include prolongation of the P-R interval, an increase in QRS duration, and an increase in Q-T interval. Complete heart block and cardiac arrest may occur at a plasma magnesium concentration above 15",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (18",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      or 7.5",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Cardiovascular effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypermagnesemia may inhibit the secretion of parathyroid hormone, causing transient hypocalcemia. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Hypocalcemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypermagnesemia may also cause non-specific symptoms such as nausea, vomiting, and flushing. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Other'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/1\">",
"      Agus ZS, Morad M. Modulation of cardiac ion channels by magnesium. Annu Rev Physiol 1991; 53:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/2\">",
"      Krendel DA. Hypermagnesemia and neuromuscular transmission. Semin Neurol 1990; 10:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/3\">",
"      Rizzo MA, Fisher M, Lock JP. Hypermagnesemic pseudocoma. Arch Intern Med 1993; 153:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/4\">",
"      Navarro-Gonz&aacute;lez JF. Magnesium in dialysis patients: serum levels and clinical implications. Clin Nephrol 1998; 49:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/5\">",
"      Cholst IN, Steinberg SF, Tropper PJ, et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/6\">",
"      Suzuki K, Nonaka K, Kono N, et al. Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects. Calcif Tissue Int 1986; 39:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/7\">",
"      Monif GR, Savory J. Iatrogenic maternal hypocalcemia following magnesium sulfate therapy. JAMA 1972; 219:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/8\">",
"      Eisenbud E, LoBue CC. Hypocalcemia after therapeutic use of magnesium sulfate. Arch Intern Med 1976; 136:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/9\">",
"      Spital A, Greenwell R. Severe hyperkalemia during magnesium sulfate therapy in two pregnant drug abusers. South Med J 1991; 84:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32914/abstract/10\">",
"      Iglesias MH, Giesbrecht EM, von Dadelszen P, Magee LA. Postpartum hyperkalemia associated with magnesium sulfate. Hypertens Pregnancy 2011; 30:481.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 849 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-84581B2B62-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32914=[""].join("\n");
var outline_f32_9_32914=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25337260\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NEUROMUSCULAR EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CARDIOVASCULAR EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HYPOCALCEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      OTHER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25337260\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/58/13220?source=related_link\">",
"      Causes and treatment of hypermagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/53/35674?source=related_link\">",
"      Inhibition of acute preterm labor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=related_link\">",
"      Preeclampsia: Management and prognosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_9_32915="Darier plaques";
var content_f32_9_32915=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Darier's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Confluent papular hyperkeratotic lesions forming large crusted plaques in a patient with Darier's disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32915=[""].join("\n");
var outline_f32_9_32915=null;
var title_f32_9_32916="Sex cord-stromal tumors of the ovary: Tumors with granulosa and Sertoli-Leydig elements";
var content_f32_9_32916=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Sex cord-stromal tumors of the ovary: Tumors with granulosa and Sertoli-Leydig elements",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32916/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32916/contributors\">",
"     David M Gershenson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32916/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32916/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32916/contributors\">",
"     Rochelle L Garcia, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32916/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32916/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/9/32916/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian sex cord-stromal tumors are a heterogeneous group of benign or malignant neoplasms that develop from the dividing cells that normally produce cells that support and surround the oocytes, including the cells that produce ovarian hormones (the nongerm cell and nonepithelial components of the gonads) (",
"    <a class=\"graphic graphic_figure graphicRef72286 \" href=\"mobipreview.htm?43/17/44307\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/1\">",
"     1",
"    </a>",
"    ]. Ovarian sex cord-stromal tumors are rare, comprising only 1.2 percent of all primary ovarian cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast with epithelial ovarian cancer, most patients with malignant sex cord-stromal tumors are diagnosed with early-stage disease; the neoplasms are generally considered to be low-grade malignant neoplasms.",
"   </p>",
"   <p>",
"    Ovarian sex cord-stromal tumors with both granulosa and Sertoli-Leydig cell elements (gynandroblastoma and sex cord tumor with annular tubules) are reviewed here. An overview of sex cord-stromal tumors and discussions about other types of sex cord-stromal tumors of the ovary (Sertoli-stromal cell tumors and tumors with granulosa and Sertoli-Leydig elements), as well as epithelial ovarian cancer, can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16087?source=see_link\">",
"     \"Overview of sex cord-stromal tumors of the ovary\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8778?source=see_link\">",
"     \"Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/22/12646?source=see_link\">",
"     \"Sex cord-stromal tumors of the ovary: Sertoli-stromal cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/52/17224?source=see_link\">",
"     \"Epithelial ovarian cancer: Pathology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31849?source=see_link\">",
"     \"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     GYNANDROBLASTOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gynandroblastoma is a very rare, usually benign, small neoplasms with both Sertoli-Leydig and Granulosa cell differentiation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/3\">",
"     3",
"    </a>",
"    ]. The diagnosis should be reserved for neoplasms containing at least 10 percent of the minor component (Sertoli-Leydig or granulosa).",
"   </p>",
"   <p>",
"    Patient age at diagnosis ranges from 16 to 65 years (average 30 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/4\">",
"     4",
"    </a>",
"    ]. These rare mixed tumors can be associated with androgen (less commonly estrogen) production, thereby causing either virilization or signs of increased estrogen production (eg, breast tenderness, postmenopausal bleeding, menstrual abnormalities, or sexual precocity in children).",
"   </p>",
"   <p>",
"    Gynandroblastomas are effectively treated with unilateral oophorectomy as only one clinically malignant case has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SEX CORD TUMOR WITH ANNULAR TUBULES",
"    </span>",
"    &nbsp;&mdash;&nbsp;These are unique types of sex cord-stromal tumors that are characterized by simple and complex annular (ring-shaped) tubules; they may be benign or malignant. They are thought to represent an intermediate between Sertoli cell and granulosa cell tumors. In one institutional series, sex cord tumors with annular tubules (SCTAT) accounted for 6 percent of all ovarian sex cord-stromal tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because SCTATs possess characteristics of both granulosa cells and sertoli cells, tumor markers that are produced by either cell type (eg, inhibin) may be useful for diagnosis and surveillance (",
"    <a class=\"graphic graphic_table graphicRef55817 \" href=\"mobipreview.htm?24/4/24653\">",
"     table 1",
"    </a>",
"    ). Almost all cases of SCTAT produce estradiol, but serum estradiol lacks sensitivity as a tumor marker, particularly when residual tumor volume is limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Non-PJS-associated (but not PJS-associated) SCTATs produce progesterone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/6,9\">",
"     6,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many of the clinical manifestations of SCTAT are related to estrogen production. Abnormal uterine bleeding is the most common presenting symptom for non-PJS-associated SCTATs (precocious puberty when they present in children). Abdominal pain or discomfort is less frequent.",
"   </p>",
"   <p>",
"    One-third of SCTATs are associated with Peutz-Jeghers syndrome (PJS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In women with PJS, the tumors usually arise in their 30s, and they are usually small (&lt;3 cm), multifocal, bilateral, calcified and asymptomatic. In contrast, non-PJS associated SCTATs are almost always unilateral, large, and uncalcified; the affected population is also younger (mid to late 20s) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. While SCTATs arising in the setting of PJS are often not detectable on clinical examination, those arising without PJS are usually palpable on abdominal or pelvic examination. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/6/37990?source=see_link\">",
"     \"Overview of Peutz-Jeghers syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With rare exception (three cases reports of malignant transformation in SCTATs associated with PJS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]), SCTATs associated with PJS are usually benign and do not have malignant potential; thus, unilateral oophorectomy is curative. However, a carcinoma (&ldquo;adenoma malignum&rdquo;) of the cervix is present in 15 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/11\">",
"     11",
"    </a>",
"    ]. The latter diagnosis is suggested by detection of a multicystic cervical mass on imaging studies; cervical cytology and colposcopy can be normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Patients with PJS should be closely followed for cervical abnormalities. Excisional biopsies of the cervix should be performed to evaluate any cervical masses.",
"   </p>",
"   <p>",
"    In contrast, women who have SCTAT without PJS have a 20 percent incidence of metastasis at initial surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/6,11,12,18\">",
"     6,11,12,18",
"    </a>",
"    ]. Surgical staging (",
"    <a class=\"graphic graphic_table graphicRef75194 \" href=\"mobipreview.htm?40/8/41099\">",
"     table 2",
"    </a>",
"    ) and treatment are similar to that of other malignant sex cord-stromal tumors and epithelial ovarian cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/48/36618?source=see_link\">",
"     \"Epithelial ovarian cancer: Initial surgical management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with advanced disease may respond to cytotoxic chemotherapy, although there is no standard regimen. A single case report documents a complete pathologic response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32916/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnosis of sex-cord stromal tumors is made by histology at time of surgical excision. Staging for malignant tumors is the same as for other primary ovarian carcinomas (",
"      <a class=\"graphic graphic_table graphicRef51205 \" href=\"mobipreview.htm?14/43/15038\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Gynandroblastoma",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gynandroblastomas are rare benign mixed tumors are associated with androgen or estrogen production, thereby causing either virilization or signs of increased estrogen production. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Gynandroblastoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend unilateral oophorectomy for diagnosis and definitive treatment (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Gynandroblastoma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Sex cord tumor with annular tubules",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sex cord tumors with annular tubules (SCTAT) can produce estradiol and progesterone and often present with abnormal uterine bleeding. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Sex cord tumor with annular tubules'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One-third of these tumors are associated with Peutz-Jeghers syndrome (PJS). All SCTATs associated with PJS are benign and do not have malignant potential. We recommend unilateral oophorectomy for diagnosis and definitive treatment in this population (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Sex cord tumor with annular tubules'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with non-PJS-associated SCTATs with intraoperative findings suggestive of malignancy, we recommend complete surgical staging including total abdominal hysterectomy and bilateral salpingo-oophorectomy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). There are insufficient data regarding conservative surgery in this rare tumor to make a recommendation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Sex cord tumor with annular tubules'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/1\">",
"      Young RH. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol 2005; 18 Suppl 2:S81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/2\">",
"      Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005; 97:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/3\">",
"      Fukunaga M, Endo Y, Ushigome S. Gynandroblastoma of the ovary: a case report with an immunohistochemical and ultrastructural study. Virchows Arch 1997; 430:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/4\">",
"      Martin-Jimenez A, Condom-Munr&oacute; E, Valls-Porcel M, et al. [Gynandroblastoma of the ovary. Review of the literature]. J Gynecol Obstet Biol Reprod (Paris) 1994; 23:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/5\">",
"      Novak ER. Gynandroblastoma of the ovary: review of 8 cases from the ovarian tumor registry. Obstet Gynecol 1967; 30:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/6\">",
"      Shen K, Wu PC, Lang JH, et al. Ovarian sex cord tumor with annular tubules: a report of six cases. Gynecol Oncol 1993; 48:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/7\">",
"      Puls LE, Hamous J, Morrow MS, et al. Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecol Oncol 1994; 54:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/8\">",
"      Gustafson ML, Lee MM, Scully RE, et al. M&uuml;llerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med 1992; 326:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/9\">",
"      Crain JL. Ovarian sex cord tumor with annular tubules: steroid profile. Obstet Gynecol 1986; 68:75S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/10\">",
"      Westerman AM, Wilson JH. Peutz-Jeghers syndrome: risks of a hereditary condition. Scand J Gastroenterol Suppl 1999; 230:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/11\">",
"      Young RH, Welch WR, Dickersin GR, Scully RE. Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 1982; 50:1384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/12\">",
"      Hart WR, Kumar N, Crissman JD. Ovarian neoplasms resembling sex cord tumors with annular tubules. Cancer 1980; 45:2352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/13\">",
"      Lele SM, Sawh RN, Zaharopoulos P, et al. Malignant ovarian sex cord tumor with annular tubules in a patient with Peutz-Jeghers syndrome: a case report. Mod Pathol 2000; 13:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/14\">",
"      Rodu B, Martinez MG Jr. Peutz-Jeghers syndrome and cancer. Oral Surg Oral Med Oral Pathol 1984; 58:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/15\">",
"      Barker D, Sharma R, McIndoe A, et al. An unusual case of sex cord tumor with annular tubules with malignant transformation in a patient with Peutz-Jeghers syndrome. Int J Gynecol Pathol 2010; 29:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/16\">",
"      Tsuruchi N, Tsukamoto N, Kaku T, et al. Adenoma malignum of the uterine cervix detected by imaging methods in a patient with Peutz-Jeghers syndrome. Gynecol Oncol 1994; 54:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/17\">",
"      Srivatsa PJ, Keeney GL, Podratz KC. Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. Gynecol Oncol 1994; 53:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32916/abstract/18\">",
"      Ahn GH, Chi JG, Lee SK. Ovarian sex cord tumor with annular tubules. Cancer 1986; 57:1066.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3226 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-6F9A708CB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32916=[""].join("\n");
var outline_f32_9_32916=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      GYNANDROBLASTOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SEX CORD TUMOR WITH ANNULAR TUBULES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Gynandroblastoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Sex cord tumor with annular tubules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/3226\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3226|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/17/44307\" title=\"figure 1\">",
"      Origins ovarian tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3226|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/4/24653\" title=\"table 1\">",
"      Ovarian tumor markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/8/41099\" title=\"table 2\">",
"      Steps in staging ovarian cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/43/15038\" title=\"table 3\">",
"      Staging ovarian peritoneal carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31849?source=related_link\">",
"      Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/48/36618?source=related_link\">",
"      Epithelial ovarian cancer: Initial surgical management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/52/17224?source=related_link\">",
"      Epithelial ovarian cancer: Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/6/37990?source=related_link\">",
"      Overview of Peutz-Jeghers syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/45/16087?source=related_link\">",
"      Overview of sex cord-stromal tumors of the ovary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8778?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/22/12646?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Sertoli-stromal cell tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_9_32917="Central line IJ post anat";
var content_f32_9_32917=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    External landmarks for the posterior approach to the internal jugular vein",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 577px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     UpToDate acknowledges the invaluable assistance of the University of Massacusetts Medical School, Department of Anatomy and Department of Emergency Medicine, including Thomas Ellis, MD and Jean Marcelin, MD, for the photographs of central venous catheter placement.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32917=[""].join("\n");
var outline_f32_9_32917=null;
var title_f32_9_32918="Clinical trials of HIV antiretroviral therapy: CCR5 antagonists";
var content_f32_9_32918=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical trials of HIV antiretroviral therapy: CCR5 antagonists",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32918/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32918/contributors\">",
"     Paul E Sax, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32918/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32918/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32918/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32918/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/9/32918/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classes of antiretroviral medications with activity against HIV include nucleoside analogs, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, integrase inhibitors and CCR5 receptor antagonists.",
"   </p>",
"   <p>",
"    CCR5 antagonists exert their antiviral activity against HIV by blocking entry of CCR5-tropic viruses into the CD4 T cell. Only one agent in this class,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    , has been approved for use in treatment-experienced HIV-infected patients.",
"   </p>",
"   <p>",
"    This topic summarizes the clinical trials that have been performed with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    in both treatment-naive and treatment-experienced patients. Data regarding other CCR5 antagonists in advanced stages of development (eg, vicriviroc) are discussed elsewhere.",
"   </p>",
"   <p>",
"    Clinical trial data regarding other classes of HIV antiretroviral medications are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/34/7720?source=see_link\">",
"     \"Clinical trials of HIV antiretroviral therapy: Integrase inhibitors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9287?source=see_link\">",
"     \"Clinical trials of HIV antiretroviral therapy: Non-nucleoside reverse transcriptase inhibitors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/16/17672?source=see_link\">",
"     \"Clinical trials of HIV antiretroviral therapy: Protease inhibitors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;CCR5 antagonists are characterized as HIV entry inhibitors.",
"   </p>",
"   <p>",
"    HIV enters CD4+ T-cells via the CD4 receptor in conjunction with one of its coreceptors: the chemokine coreceptor 5 (CCR5) or the CXC chemokine coreceptor 4 (CXCR4) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/1\">",
"     1",
"    </a>",
"    ]. Viruses which use the CCR5 coreceptor are called \"R5 viruses\" while others that use the CXCR4 coreceptor are called \"X4 viruses\". (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/34/5674?source=see_link\">",
"     \"Immunology of HIV-1 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Coreceptor usage is dependent upon the immune status of the host. Viral strains from patients with early stage disease use the CCR5 coreceptor. In contrast, approximately one-half of viral strains from patients with advanced immunosuppression utilize the CXCR4 coreceptor, or both the CCR5 and the CXCR4 receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/2\">",
"     2",
"    </a>",
"    ]. These viruses are referred to as \"dual-mixed\" tropic viruses.",
"   </p>",
"   <p>",
"    The CD4-gp120 interaction induces conformational changes in the viral envelope that expose the chemokine receptor binding site. In patients with R5 virus,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    binds to the transmembrane coreceptor cavity, which prevents interaction of the V3 loop of gp120 with the CCR5 coreceptor, thus preventing viral entry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/3\">",
"     3",
"    </a>",
"    ]. Additional antiviral effects include the inhibition of syncytia formation (fusion between infected and uninfected CD4 cells) and blockade of gp120-induced apoptosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TROPISM ASSAYS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A phenotypic tropism assay is recommended by major consensus committees prior to initiation of therapy with CCR5 antagonists because these drugs are not active against X4 or dual-mixed tropic viruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Tropism is determined using the HIV env gene, which is amplified from plasma RNA to generate recombinant virions; these virions are subsequently used to infect human cell lines expressing CD4 and either CXCR4 or CCR5 receptors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/3\">",
"     3",
"    </a>",
"    ]. The tropism assay is similar to an HIV resistance phenotype, and can determine whether a response from a CCR5 antagonist should be expected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/48/4873?source=see_link&amp;anchor=H24#H24\">",
"     \"Overview of HIV drug resistance testing assays\", section on 'Tropism assays'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Repeat tropism testing may be considered if a patient has virologic failure after initiating a CCR5 antagonist since a minority species of CXCR-4 or dual-tropic viruses may have been present at baseline, but not detected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/7\">",
"     7",
"    </a>",
"    ]. However, the \"enhanced sensitivity\" Trophile assay (available in the United States through Monogram Sciences) detects X4 virus at levels &lt;0.3 percent, which reduces the false negative rate seen with the first generation test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/48/4873?source=see_link&amp;anchor=H24#H24\">",
"     \"Overview of HIV drug resistance testing assays\", section on 'Tropism assays'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Genotypic tropism assays that return results more quickly than the Trophile assay are available commercially. However, such assays have not yet been conclusively validated to correlate with antiviral response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    , and hence are not recommended in the United States at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MARAVIROC",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     Maraviroc",
"    </a>",
"    (Selzentry) is a selective and reversible CCR5 coreceptor antagonist with a wide range of activity against clinical HIV isolates, including those with multi-drug resistance to other drug classes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/9\">",
"     9",
"    </a>",
"    ]. Maraviroc was approved for use in treatment-experienced patients by the United States Food and Drug Administration in 2007 at 300 mg orally twice daily. It is not active in patients with non-R5 tropic viruses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     \"Maraviroc: Drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Treatment-experienced patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;In HIV-infected patients,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    monotherapy for 10 days reduced HIV RNA by up to 1.6 log with 300 mg daily and 1.8 log with 300 mg twice daily [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/11\">",
"     11",
"    </a>",
"    ]. In a study that evaluated viral tropism of these patients, no CXCR4-using viruses were identified at the end of the study except in two patients; further phylogenetic analysis demonstrated that these variants probably emerged from a pretreatment reservoir and did not represent a phenotypic shift [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     MOTIVATE trials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two double-blind placebo-controlled phase 3 trials (MOTIVATE 1 and MOTIVATE 2;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     Maraviroc",
"    </a>",
"    versus Optimized Therapy In Viremic Antiretroviral Treatment-Experienced patients) were conducted in a total of 1049 HIV-infected patients with R5 viruses (as documented on tropism testing) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients were randomly assigned to one of three regimens including maraviroc once daily, maraviroc twice daily, or placebo; each arm also included optimized background therapy (OBT) based on treatment history and drug resistance testing.",
"   </p>",
"   <p>",
"    The mean baseline HIV RNA level was 72,400",
"    <span class=\"nowrap\">",
"     copies/mL",
"    </span>",
"    and the median CD4 cell count was 169",
"    <span class=\"nowrap\">",
"     cells/microL.",
"    </span>",
"    All of the patients had a history of taking one or more drugs from three different classes for a minimum of six months or had documented three-class drug resistance through genotypic or phenotypic testing. Use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=see_link\">",
"     darunavir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13320?source=see_link\">",
"     etravirine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/27/10678?source=see_link\">",
"     raltegravir",
"    </a>",
"    was not allowed since there was no information on drug interactions at the time of enrollment. The 48-week results demonstrated the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean decline in HIV RNA was greater in the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      -containing arms than in the placebo arm (-1.66 and -1.82 log [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/14\">",
"       14",
"      </a>",
"      ]",
"      <span class=\"nowrap\">",
"       copies/mL",
"      </span>",
"      with once-daily and twice-daily regimens, respectively, versus -0.80 with placebo in MOTIVATE 1; and -1.72 and -1.87 log [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/14\">",
"       14",
"      </a>",
"      ]",
"      <span class=\"nowrap\">",
"       copies/mL,",
"      </span>",
"      respectively, versus -0.76 with placebo in MOTIVATE 2).",
"     </li>",
"     <li>",
"      Significantly more patients in the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      once-daily and twice-daily arms achieved viral suppression than in the placebo arms in both trials (42 and 47 percent, respectively, versus 16 percent in the placebo group in MOTIVATE 1; and 45 percent in both maraviroc dosing arms versus 18 percent in the placebo arm in MOTIVATE 2).",
"     </li>",
"     <li>",
"      In both studies, the increase in CD4 cell counts from baseline to week 48 was similar in the two",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      dosing groups, but significantly greater than the increase in the placebo group. For example, in MOTIVATE 2, the mean increases were 122 and 128",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"      in the groups receiving maraviroc (once daily and twice daily, respectively) as compared with 69",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"      in the placebo group.",
"     </li>",
"     <li>",
"      The frequency of adverse events was similar in all dosing arms. Discontinuation rates were much higher in the OBT plus placebo arms (68 percent) compared with those taking",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      (39 percent in the once-daily arm and 35 percent in the twice-daily arm). The greater rates of discontinuation in the placebo arm were mainly related to virologic failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These two trials support the efficacy of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    in treatment-experienced HIV-infected patients with R5-tropic virus, including patients with negative prognostic factors, such as low CD4 cell counts or high level viremia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although efficacy and safety data were similar between the two dosing groups, twice-daily dosing of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    was recommended by the investigators. This recommendation was based on its pharmacokinetic profile and 24-week data which showed that a greater proportion of patients with poor prognostic factors (eg, a CD4 cell count &lt;50",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    a high viral load, or few active agents within the ART regimen) attained viral suppression with twice-daily dosing compared to those in the once daily arm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Consistent with prior studies, the \"first use\" of other agents in OBT background led to more favorable virologic outcomes in the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    arms compared to patients who were \"recycling\" drugs to which they had already been exposed (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/2/7205?source=see_link\">",
"     enfuvirtide",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Of the patients who had virologic failure, more than 50 percent of patients in the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    arms had evidence of X4 virus, as compared with only 6 percent who received placebo. This observation is consistent with increased detection of preexisting X4 virus when R5 virus is selectively suppressed by a selective CCR5-blocking agent.",
"   </p>",
"   <p>",
"    Although a phenotypic switch from R5 to X4 virus in natural infection is associated with clinical deterioration, this was not observed in the MOTIVATE trials. In fact, the patients in the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    arms with X4 virus had greater increases in CD4 cell counts than those in the placebo arms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/15\">",
"     15",
"    </a>",
"    ]. This suggests that maraviroc does not select for a more pathogenic virus, although the overall follow-up was relatively short [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Treatment-naive patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    in treatment-naive patients was evaluated in a 48-week multicenter, randomized, double-blind non-inferiority trial (the MERIT study) that compared maraviroc to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    , both in combination with",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"      zidovudine",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/7/38007?source=see_link\">",
"      lamivudine",
"     </a>",
"     &nbsp;[",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/17\">",
"      17",
"     </a>",
"     ].",
"    </span>",
"    Maraviroc was administered as a single daily dose or on a twice-daily schedule.",
"   </p>",
"   <p>",
"    At week 16, the Data Safety and Monitoring Board closed the once-daily arm because of inadequate response rates. At 48 weeks, 65 percent of the twice-daily",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    group and 69 percent of the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    group attained viral load &lt;50",
"    <span class=\"nowrap\">",
"     copies/mL.",
"    </span>",
"    Although the difference in response rates was relatively modest, maraviroc failed to meet the prespecified criteria for noninferiority.",
"   </p>",
"   <p>",
"    However, a posthoc analysis showed that some patients had acquired X4 virus between screening and trial entry and others had X4 virus at baseline that was detected only with an enhanced tropism assay (ie, ESTA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/18\">",
"     18",
"    </a>",
"    ]. With elimination of the patients who had X4 virus from the final statistical analysis, viral suppression rates with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    were found to be noninferior to the comparator arm at 48 weeks (approximately 68 percent).",
"   </p>",
"   <p>",
"    The rate of adverse reactions requiring treatment discontinuation was greater in the EFV recipients (14 percent versus 4 percent), while the rate of discontinuations for virologic failure was greater in the MVC recipients (12 percent versus 4 percent). Approximately one-third of the study population was black; whether altered drug metabolism of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    played a role in the frequency of central nervous system adverse events is unknown since pharmacogenetic analyses were not performed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/18/37162?source=see_link&amp;anchor=H14#H14\">",
"     \"Pharmacology of non-nucleoside reverse transcriptase inhibitors\", section on 'Neuropsychiatric side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of note, CD4 cell gains were significantly greater in patients in the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    arm (170 versus 144",
"    <span class=\"nowrap\">",
"     cells/microL).",
"    </span>",
"    The mechanism for this observation is unknown; whether increased numbers of CD4 cells are due to reduced immune activation or decreased sequestration or some other mechanism is the subject of current investigation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    is also approved for use in the treatment-naive patient, it is not considered a first-line agent since there are abundantly more data and clinical experience with other antiretroviral medications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Adverse events",
"    </span>",
"    &nbsp;&mdash;&nbsp;To date,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    appears to be well tolerated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/17\">",
"     17",
"    </a>",
"    ]. The most common adverse reactions noted in studies of maraviroc included cough, pyrexia, upper respiratory infections, rash, musculoskeletal symptoms, lightheadedness, and abdominal pain. Dosing of maraviroc depends on whether or not it is being administered with inducers or inhibitors of cytochrome p450 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The FDA is requiring long-term follow-up studies to examine its side effect profile more closely in terms of cardiovascular effects and liver toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Cardiovascular events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eleven study participants (1.3 percent) who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    had cardiovascular events including myocardial ischemia during the phase 3 studies; the relationship of these events to maraviroc is uncertain since these patients had either known cardiac disease or cardiac risk factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Hepatotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe hepatotoxicity occurred in one of 1300 patients who were enrolled in the phase",
"    <span class=\"nowrap\">",
"     2b/3",
"    </span>",
"    clinical program [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/20\">",
"     20",
"    </a>",
"    ]. However, this patient was also taking other agents with potential hepatotoxicity (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ). Concern about hepatotoxicity with CCR5 antagonists was heightened when the development of aplaviroc (another drug in this class) was halted due to severe hepatotoxicity, raising the possibility of a class effect side effect.",
"   </p>",
"   <p>",
"    Subsequent studies of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    have not identified hepatotoxicity as occurring more commonly than in control arms that did not receive the drug, although the drug has not been studied extensively in patients with underlying chronic viral hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/15,21\">",
"     15,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other serious events",
"    </span>",
"    &nbsp;&mdash;&nbsp;There has been some concern that CCR5 blockade may be associated with a concomitant rise in malignancies; however, this concern has not been supported by clinical trial data.",
"   </p>",
"   <p>",
"    In addition, genetic deficiency of the CCR5 receptor has been linked to an increased predisposition to West Nile virus infection; to date, there are no data suggesting an increased risk of West Nile virus infection among clinical trial participants taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    , although there was some increased risk of other infections, such as herpes zoster [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     VICRIVIROC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vicriviroc is another CCR5 receptor antagonist with in vitro activity against HIV. However, in January 2010, the manufacturer of vicriviroc announced that it would not seek approval of this agent for treatment-experienced patients based on results of two phase III trials; the data supporting this decision have not yet been published [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/22\">",
"     22",
"    </a>",
"    ]. Increased virologic relapse rates in vicriviroc-containing arms were reported in an early phase II trial and a pilot study in treatment-naive patients. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/23\">",
"     23",
"    </a>",
"    ]. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32918/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HIV enters CD4+ T-cells via the chemokine receptor 5 (CCR5) or CXC chemokine receptor 4 (CXCR4) or both; CCR5 antagonists work at the level of the CCR5 receptor and block HIV infection. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mechanism of action'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because CCR5 antagonists are not active against CXCR4 or dual-mixed tropic viruses, a pretreatment screening test should be performed to assess viral tropism prior to initiation of a CCR5 inhibitor. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Tropism assays'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In treatment-experienced patients with CCR5 tropic virus at baseline,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      plus an optimized background regimen led to greater virologic suppression and immunologic benefit than placebo plus an optimized background regimen. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Maraviroc'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       Maraviroc",
"      </a>",
"      is generally well tolerated; longer follow-up is required to assess any potential effect on cardiovascular morbidity or liver injury. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Adverse events'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although virologic failure may be associated with emergence of X4 virus in treatment-experienced patients receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      , there is no evidence of immunologic deterioration that had been previously described with R5 to X4 phenotypic switching during natural infection. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Maraviroc'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      is also approved for use in the treatment-naive patient, it is not considered a first-line agent since there are much greater efficacy and safety data with other antiretroviral medications. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment-naive patients'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/1\">",
"      Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/2\">",
"      Hunt PW, Harrigan PR, Huang W, et al. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis 2006; 194:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/3\">",
"      Soriano V, Geretti AM, Perno CF, et al. Optimal use of maraviroc in clinical practice. AIDS 2008; 22:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/4\">",
"      Corbeau P, Reynes J. CCR5 antagonism in HIV infection: ways, effects, and side effects. AIDS 2009; 23:1931.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: file://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&amp;Search=Off&amp;GuidelineID=7&amp;ClassID=1 (Accessed on April 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/6\">",
"      Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/7\">",
"      Vandekerckhove L, Verhofstede C, Vogelaers D. Maraviroc: integration of a new antiretroviral drug class into clinical practice. J Antimicrob Chemother 2008; 61:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/8\">",
"      Trinh L, Han D, Huang W, et al. Technical validation of an enhanced sensitivity Trofile HIV coreceptor tropism assay for selecting patients for therapy with entry inhibitors targeting CCR5. Antivir Ther 2008; 13 Suppl 3:A128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/9\">",
"      MacArthur RD, Novak RM. Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents. Clin Infect Dis 2008; 47:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/10\">",
"      Saag M, Goodrich J, F&auml;tkenheuer G, et al. A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1. J Infect Dis 2009; 199:1638.",
"     </a>",
"    </li>",
"    <li>",
"     Fatkenheuer G, Pozniak A, Johnson M, et al. Evaluation of doing frequency and food effect on viral load reduction during short-term monotherapy with UK-427,857 a novel CCR5 antagonist. In: Program and abstracts of the XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand. Abstract TuPeB4489.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/12\">",
"      Westby M, Lewis M, Whitcomb J, et al. Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir. J Virol 2006; 80:4909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/13\">",
"      Gulick RM, Lalezari J, Goodrich J, et al. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med 2008; 359:1429.",
"     </a>",
"    </li>",
"    <li>",
"     Lalezari J, Goodrich J, DeJesus E, et al. Efficacy and safety of Maraviroc plus optimized background therapy in viremic ART-experienced patient infected with CCR5-tropic HIV-1: 24 week results of a phase 2b/3 study in the US and Canada. Conference on Retroviruses and Opportunistic Infections, February 25-28, 2007, Los Angeles. Abstract #104bLB.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/15\">",
"      F&auml;tkenheuer G, Nelson M, Lazzarin A, et al. Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N Engl J Med 2008; 359:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/16\">",
"      Dolin R. A new class of anti-HIV therapy and new challenges. N Engl J Med 2008; 359:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/17\">",
"      Cooper DA, Heera J, Goodrich J, et al. Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection. J Infect Dis 2010; 201:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/18\">",
"      Vandekerckhove L, Verhofstede C, Vogelaers D. Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients. J Antimicrob Chemother 2009; 63:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/19\">",
"      Two new drugs for HIV infection. Med Lett Drugs Ther 2008; 50:2.",
"     </a>",
"    </li>",
"    <li>",
"     Mayer H. Case study of a patient with serious hepatotoxicity in maraviroc IIB/III trial. Presented at Targeting HIV Entry - First International Workshop. Bethesda, MD, December 3, 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/21\">",
"      Clotet B. CCR5 inhibitors: promising yet challenging. J Infect Dis 2007; 196:178.",
"     </a>",
"    </li>",
"    <li>",
"     Gathe J, et al. Phase 3 Trials of Vicriviroc in Treatment-experienced Subjects Demonstrate Safety but Not Significantly Superior Efficacy over Potent Background Regimens Alone. Conference on Retroviruses and Opportunistic Infections, February 16-19, 2010, San Francisco, CA, Abst# 54LB.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32918/abstract/23\">",
"      Landovitz RJ, Angel JB, Hoffmann C, et al. Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection. J Infect Dis 2008; 198:1113.",
"     </a>",
"    </li>",
"    <li>",
"     Dunkle M, et al. 50th ICAAC; Boston, MA; September 12-15, 2010; Abst. H-938a.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3784 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-202.43.93.2-77D3A94D3A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32918=[""].join("\n");
var outline_f32_9_32918=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISM OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TROPISM ASSAYS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MARAVIROC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Treatment-experienced patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - MOTIVATE trials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Treatment-naive patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Adverse events",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Cardiovascular events",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Hepatotoxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other serious events",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      VICRIVIROC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/34/7720?source=related_link\">",
"      Clinical trials of HIV antiretroviral therapy: Integrase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/4/9287?source=related_link\">",
"      Clinical trials of HIV antiretroviral therapy: Non-nucleoside reverse transcriptase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/16/17672?source=related_link\">",
"      Clinical trials of HIV antiretroviral therapy: Protease inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/34/5674?source=related_link\">",
"      Immunology of HIV-1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=related_link\">",
"      Maraviroc: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/48/4873?source=related_link\">",
"      Overview of HIV drug resistance testing assays",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/18/37162?source=related_link\">",
"      Pharmacology of non-nucleoside reverse transcriptase inhibitors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_9_32919="Peanut, tree nut, and seed allergy: Management";
var content_f32_9_32919=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Peanut, tree nut, and seed allergy: Management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32919/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32919/contributors\">",
"     Hugh A Sampson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32919/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32919/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32919/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32919/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/9/32919/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peanut, tree nut, and seed allergies are some of most common food allergies in both children and adults. These allergies tend to cause severe reactions and usually persist over time.",
"   </p>",
"   <p>",
"    This topic reviews various aspects of management of peanut, tree nut, and seed allergy, including instructions about avoidance of these allergens, education in the proper management of accidental exposures, and monitoring for resolution of the allergy. The epidemiology, pathogenesis, clinical features, and diagnosis of peanut, tree nut, and seed allergy are discussed separately. General discussions of food allergy are presented separately in appropriate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9654?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of food allergy in the specific settings of schools and camps is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3705?source=see_link\">",
"     \"Food allergy in schools and camps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIETARY RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of peanut, tree nut, and seed allergies begins with instructions about avoidance of products containing these foods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Avoidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most straightforward approach in managing any food allergy is complete avoidance of the culprit food (",
"    <a class=\"graphic graphic_table graphicRef75071 \" href=\"mobipreview.htm?31/41/32412\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56449 \" href=\"mobipreview.htm?0/13/221\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56144 \" href=\"mobipreview.htm?35/47/36604\">",
"     table 3",
"    </a>",
"    ). Foods that are at higher risk of containing peanut, tree nuts, or seeds include African, Asian, and Mexican dishes, baked goods (eg, pastries, cookies, crackers, bread), and candy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/28/12746?source=see_link&amp;anchor=H7#H7\">",
"     \"The natural history of childhood food allergy\", section on 'Role of avoidance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Counseling about avoidance should include discussions about the following issues:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cross-contact and hidden ingredients &mdash; Patients must be counseled about the potential for accidental exposure to food allergens via cross-contact (ie, inadvertent exposure to the allergenic food by contamination of \"safe\" foods with small amounts of the culprit food). This can happen anywhere food is served, including restaurants and bakeries. Peanut butter is sometimes used as a thickener in chili and sauces. Seed and legume flours are used in baked goods and pastas. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=see_link&amp;anchor=H5#H5\">",
"       \"Management of food allergy: Avoidance\", section on 'Skills for daily living'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Food labels &mdash; Patients must read all food labels (",
"      <a class=\"graphic graphic_table graphicRef75071 \" href=\"mobipreview.htm?31/41/32412\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef56449 \" href=\"mobipreview.htm?0/13/221\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef56144 \" href=\"mobipreview.htm?35/47/36604\">",
"       table 3",
"      </a>",
"      ). Legislation was enacted in the United States mandating that the ingredients labels on food packages clearly identify the presence of eight specified allergenic foods, including peanut, tree nuts, egg, milk, wheat, soybeans, fish, and Crustacean shellfish. However, seeds such as sesame were not included. Other countries are addressing issues of food labeling as well. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=see_link&amp;anchor=H6#H6\">",
"       \"Management of food allergy: Avoidance\", section on 'Food labeling'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Advisory labeling &mdash; Some products in the United States may have advisory labeling, such as \"may contain peanut\". The most commonly labeled items include chocolate candy, cookies, and baking mixes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/1\">",
"       1",
"      </a>",
"      ]. This type of labeling is not currently regulated. The risk of allergic reactions to these products is not known, but contamination with clinically significant amounts of peanut allergen was found in a small proportion of products with peanut advisory labeling [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/2\">",
"       2",
"      </a>",
"      ]. Some individuals with peanut allergy react to minute amounts of peanut allergen, and these reactions can be severe [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/3-7\">",
"       3-7",
"      </a>",
"      ]. However, it is rare for a patient to know what their threshold dose is for triggering a reaction, and it may vary when the individual has a viral infection, participates in aerobic activities, or is taking nonsteroidal antiinflammatory drugs (NSAIDs). Thus, we recommend that patients with peanut, tree nut,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      seed allergy avoid all products with advisory labeling for these foods (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=see_link&amp;anchor=H9#H9\">",
"       \"Management of food allergy: Avoidance\", section on 'Advisory labeling'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H19#H19\">",
"       \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Threshold dose'",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      About one-third of patients with peanut allergy react to tree nuts; therefore, unless they are ingesting certain tree nuts, it is important to rule-out possible tree nut allergies before allowing these patients to ingest tree nuts. We often recommend that young patients with peanut allergy avoid all tree nuts primarily for safety reasons. Younger children are more likely to be confused about the identification of various nuts [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/8\">",
"       8",
"      </a>",
"      ] and do not understand all of the issues related to contamination and cross-contact. Once they are old enough to understand these issues, we allow patients who do not have tree nut allergies to eat tree nuts that they can visualize, and therefore identify, or that are contained in commercial, labeled foods. We discourage the ingestion of nuts in products from bakeries or restaurants, since peanuts are not uncommonly",
"      <span class=\"nowrap\">",
"       added/substituted",
"      </span>",
"      for tree nuts. We recommend that children just eat the \"allowed\" nuts when with their family, and continue to avoid peanut and all tree nuts at",
"      <span class=\"nowrap\">",
"       school/camp",
"      </span>",
"      to avoid issues with cross-contact, confusion regarding which nuts to avoid, and misidentification.",
"     </li>",
"     <li>",
"      Unexpected and non-food sources &mdash; Skin preparations and hair products may have ingredients derived from peanut, tree nuts, or seeds. Some medications, such as a few metered dose inhalers and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      , contain soy lecithin. Soy lecithin is derived from highly processed soy oil and has very little, if any, soy protein. It can be consumed safely by nearly all patients with soy allergy. Thus, these medications are unlikely to be unsafe in patients with peanut allergy, and therefore, we do not tell patients with peanut allergy to avoid these medications. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=see_link&amp;anchor=H15#H15\">",
"       \"Management of food allergy: Avoidance\", section on 'Food allergens in non-food items'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical scenarios",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peanut, tree nuts, and seeds are not essential components of the diet for most people. However, these foods are found in many products. The most straightforward approach in managing any food allergy is",
"    <strong>",
"     complete",
"    </strong>",
"    avoidance of the culprit food and all similar foods. This strategy would be logically expected to minimize the chances of accidental exposure to the culprit food through cross-contact.",
"   </p>",
"   <p>",
"    However, there may be disadvantages to the strategy of avoiding all similar foods. There is some evidence, for example, that removing foods from the diet can increase the risk of becoming allergic to them [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/9\">",
"     9",
"    </a>",
"    ]. Possible reasons for the heightened sensitivity include both lack of exposure through ingestion and the opposite explanation, namely, ongoing low level exposure (through hidden sources or cross-contact). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/42/43689?source=see_link\">",
"     \"Pathogenesis of food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, the clinician's recommendations must carefully balance the patient's preferences with what is known about cross-reactivity among these foods if a patient with an allergy to peanut or a certain tree nut or seed wishes to continue eating other forms of nuts or seeds. The severity of the patient's reaction, age of the patient, and nutritional needs also influence the decision. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/63/2042?source=see_link\">",
"     \"Food allergens: Overview of clinical features and cross-reactivity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H20#H20\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Allergies to other foods'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following scenarios illustrate some of the issues involved and our management approach. Individual clinicians may decide to adopt different strategies depending upon their level of expertise and the resources available (eg, ability to perform oral food challenges).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who have experienced life-threatening anaphylaxis to peanut or a specific tree nut or seed, we recommend avoidance of that specific food, and also suggest avoidance of all common",
"      <strong>",
"       clinically",
"      </strong>",
"      cross-reactive foods. Peanut and tree nuts are often processed in the same facilities, and therefore there is a risk of accidental exposure due to cross-contact. Furthermore, young patients with an allergy to peanut are at high risk for developing an allergy to tree nuts. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H20#H20\">",
"       \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Allergies to other foods'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Specifically, we recommend that patients with severe peanut allergy avoid tree nuts and cross-reactive legumes until an evaluation is performed, and it is clearly determined that they can tolerate these foods. In younger children with severe peanut allergy, we suggest avoidance of lupine and all tree nuts, in addition to peanut, even if testing is negative. In older children and adults, we allow them to eat tree nuts and lupine if they wish",
"      <strong>",
"       and",
"      </strong>",
"      if we have determined that they are not reactive (ie, a negative test is sufficient if there is no reaction history, otherwise we perform a food challenge to confirm lack of reactivity) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/10\">",
"       10",
"      </a>",
"      ]. We counsel these patients about the potential increased risk of cross-contact with this approach.",
"      <br/>",
"      <br/>",
"      We suggest avoidance of all tree nuts for patients with a severe tree nut allergy. These patients may continue to eat peanut if it is already in their diet. If peanut is not already in their diet, it may be introduced if testing is negative. We counsel them about the precautions discussed above if they choose to eat peanut.",
"     </li>",
"     <li>",
"      We are more flexible in our approach for patients with non-life threatening reactions to peanut, tree nuts,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      seeds. We do not discourage patients from avoiding peanut and all tree nuts if that is what they prefer to do. However, a careful evaluation must be performed to determine which cross-reacting foods that a patient has not eaten in the past may be safely consumed if a patient wishes to include some of these foods in their diet.",
"      <br/>",
"      <br/>",
"      As an example, a patient who develops an allergy to a tree nut that is moderate in severity, and has been avoiding peanut and all tree nuts may ask about the safety of eating peanut, which had not been a regular component of the patient's diet before the reaction. In this case, we would first perform skin testing with a commercial peanut extract. If negative, we would allow the ingestion of peanut because the experience in our clinic suggests the negative predictive value of skin prick testing for peanut is generally high. If the skin test was positive to peanut, we would evaluate the level of peanut-specific IgE in the blood. If the level was &lt;15",
"      <span class=\"nowrap\">",
"       kU",
"       <sub>",
"        A",
"       </sub>",
"       /L",
"      </span>",
"      and the patient had an interest in eating peanut, we would perform a graded challenge to determine whether there was true clinical reactivity, (because false-positive skin tests are not uncommon, and patients may have low levels of allergen-specific IgE without developing clinical symptoms). An oral food challenge with peanut would also be performed if there were any clinical suspicion of peanut allergy, or if the clinician were uncomfortable proceeding without additional evaluation.",
"      <br/>",
"      <br/>",
"      It is typically easier to liberalize the diet to allow peanut, compared with allowing some tree nuts, in people with a tree nut allergy. One can purchase commercial grade peanut butter that is not contaminated with tree nuts, but it is more complicated to find tree nut-containing products without cross-contact risks.",
"     </li>",
"     <li>",
"      We allow people to continue to eat nuts or seeds that have not caused symptoms in the recent past, and which they have eaten regularly (similar to having just passed an oral food challenge), if they wish to do so. As an example, a patient with a newly diagnosed allergy to cashew who continued to eat peanut and almond without incident after the reaction to cashew can continue to eat peanut, other tree nuts (except pistachio in this case, since cross-reactivity is higher), and seeds. We discuss with the patient that by keeping peanut and almond in the diet, there is some increased risk of accidental exposure to cashew due to cross-contact. In addition, we discuss the rare possibility of developing additional tree nut allergies over time if the patient is a young child.",
"     </li>",
"     <li>",
"      A patient sometimes presents with a positive test to a food, such as peanut, that they are currently eating on a regular basis. We do not advise removal of the food from the diet in this case. However, we do discuss with the patient that on rare occasions, individuals may convert from sensitization to clinical reactivity. In most cases in which this occurs, peanut has been removed from the diet because of a \"positive\" test result despite no history of clinical reactivity, and clinical symptoms develop when peanut is reintroduced into the diet [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another common scenario is the patient who was tested for food allergies because of a history of other food allergies, atopic disease, or family history, and tested positive to a food such as peanut, but has never ingested the food. In two studies, half of a group of atopic, peanut-naive children who had a skin test reaction to peanut of &ge;3 mm or peanut-specific IgE &ge;0.35",
"      <span class=\"nowrap\">",
"       kU",
"       <sub>",
"        A",
"       </sub>",
"       /L",
"      </span>",
"      reacted to peanut when challenged [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. In this situation, we take into consideration the size of the skin prick test reaction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the level of specific IgE, the age of the patient, and",
"      <span class=\"nowrap\">",
"       patient/family",
"      </span>",
"      preferences.",
"      <br/>",
"      <br/>",
"      We generally advise avoidance of the food if the patient is less than five years of age",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the test is strongly \"positive\". This age cutoff is for practical, not immunologic, reasons. There is no need to eat peanut. These children often have sensitization to other foods that are more essential to the diet and need to be dealt with first. In addition, clarifying whether or not the child is allergic to peanut is more important once they reach school age. Finally, the older child is better able to cooperate with a challenge and communicate the development of subjective symptoms.",
"      <br/>",
"      <br/>",
"      We would challenge a child &lt;5 years of age if the parent wanted the child to eat peanut products, peanut was the child&rsquo;s only sensitization, and the skin prick test reaction was &lt;8 mm and the peanut-specific IgE &lt;2",
"      <span class=\"nowrap\">",
"       kU",
"       <sub>",
"        A",
"       </sub>",
"       /L.",
"      </span>",
"      We are more likely to consider an oral food challenge to determine presence or absence of clinical reactivity in the older patient or the individual with more equivocal test results. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9654?source=see_link&amp;anchor=H5#H5\">",
"       \"Peanut, tree nut, and seed allergy: Diagnosis\", section on 'Diagnostic pitfalls'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We generally do not restrict other legumes from the diet in patients with peanut allergy, with the exception of lupine, since it appears to have greater clinical cross-reactivity with peanut. Most children have already eaten and tolerated various legumes (eg, soy, pea, string bean, etc.) prior to their initial peanut reaction. We typically advise patients that they may continue to eat the tolerated legumes and introduce others into the diet without additional testing. Of note, there is a high rate of false positive tests to legumes in patients with peanut allergy, making screening tests unreliable. We will often test patients who are highly allergic to peanut to other legumes by performing skin tests and sometimes serum IgE tests if they have not already shown tolerance to at least several legumes, or if there are concerns of reactions to some legumes. Introduction of additional legumes may require clinician-supervised oral food challenges depending upon these results and the degree of clinical concern.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF ACUTE IgE-MEDIATED REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Identification of individuals with IgE-mediated allergy is important, because these patients are at risk for severe reactions. The majority of allergic reactions to peanut, tree nuts, or seeds are systemic. These foods are also among the more common causes of food-induced anaphylaxis, particularly fatal and near-fatal anaphylaxis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H3#H3\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Types of reactions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/0/38920?source=see_link\">",
"     \"Food-induced anaphylaxis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/13/1241?source=see_link\">",
"     \"Fatal anaphylaxis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The severity of symptoms in a given individual with peanut, tree nut, or seed allergy may vary considerably between reactions. In addition, the severity of an initial reaction does not predict the severity of subsequent reactions. Furthermore, skin test and specific-IgE results are not predictive of the severity of reactivity to a food. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9654?source=see_link\">",
"     \"Peanut, tree nut, and seed allergy: Diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Members of a United States-based registry of individuals with peanut",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tree nut allergy reported that subsequent reactions due to accidental ingestion were commonly more severe than their initial reactions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An Australian study of peanut allergy found that 30 percent of patients who had experienced anaphylaxis had preceding milder reactions.",
"     </li>",
"     <li>",
"      In a small study of children with peanut allergy in Singapore, half of those who had an accidental exposure had a reaction of greater severity than their initial reaction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children whose only apparent clinical manifestation of food allergy is atopic dermatitis are at risk of an acute systemic reaction upon reintroduction of that food after an elimination diet [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/16-18\">",
"       16-18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accordingly, we suggest that individuals diagnosed with IgE-mediated peanut, tree nut, or seed allergy have an",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    autoinjector(s) available at all times [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/19\">",
"     19",
"    </a>",
"    ]. In addition, the patient should have a written anaphylaxis emergency action plan (",
"    <a class=\"graphic graphic_form graphicRef60439 \" href=\"mobipreview.htm?2/42/2722\">",
"     form 1",
"    </a>",
"    ). These measures are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MONITORING FOR RESOLUTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with peanut, tree nut,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    seed allergies should be monitored for resolution (\"outgrowing\") of the allergy. The steps to take to determine if an allergy has resolved are covered in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H22#H22\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Natural history and prognosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/28/12746?source=see_link\">",
"     \"The natural history of childhood food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peanut allergy rarely may recur in patients who have passed an oral food challenge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/9,20\">",
"     9,20",
"    </a>",
"    ]. The first cases of reported recurrence occurred in children who did not incorporate peanut into the regular diet after passing the challenge, although it is not clear whether these children refused to eat peanut because they were experiencing some discomfort. In addition, subsequent cases have been reported in patients who regularly consumed peanut [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32919/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We advise incorporating the food into the regular diet after passing a food challenge. We also advise patients to maintain an emergency plan for at least one year, until they have proven that the food is tolerated in the regular diet in typical quantities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/59/20409?source=see_link\">",
"     \"Oral food challenges for diagnosis and management of food allergies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF YOUNGER SIBLINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Younger siblings of a child with peanut allergy are at increased risk of developing an allergy to peanut compared with the general population, particularly if they show other signs of allergic disease such as atopic dermatitis. Thus, we recommend that siblings with atopic symptoms be evaluated before peanut is introduced into their diet. We typically evaluate the sibling of a child with peanut allergy with skin prick tests (SPTs), and if positive, obtain a peanut-specific IgE level to help determine the likelihood that the child will react to peanut. There are no data on the risk to siblings of children with tree nut or seed allergy. We often use SPTs to evaluate younger siblings of children who have experienced severe reactions to tree nuts or seeds. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H12#H12\">",
"     \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Familial factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/37/25175?source=see_link&amp;anchor=H12#H12\">",
"     \"Introducing formula and solid foods to infants at risk for allergic disease\", section on 'Introduction of solid foods to high risk infants'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     FUTURE TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no treatments that can cure or provide long-term remission from food allergy. However, several treatment strategies are under investigation. These approaches are either allergen-specific or aimed at modulating the overall allergic response. These investigational therapies are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44057?source=see_link\">",
"     \"Future therapies for food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/35/17971?source=see_link\">",
"       \"Patient information: Peanut allergy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/47/29429?source=see_link\">",
"       \"Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/35/35379?source=see_link\">",
"       \"Patient information: Food allergy treatment and avoidance (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Management of peanut, tree nut, and seed allergies includes instructions about avoidance of products containing these foods and determination of which similar foods may be ingested safely. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Dietary recommendations'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=see_link\">",
"       \"Management of food allergy: Avoidance\"",
"      </a>",
"      .) and (",
"      <a class=\"graphic graphic_table graphicRef75071 \" href=\"mobipreview.htm?31/41/32412\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef56449 \" href=\"mobipreview.htm?0/13/221\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef56144 \" href=\"mobipreview.htm?35/47/36604\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The most straightforward approach in managing any food allergy is complete avoidance of the culprit food and all similar foods. However, there are disadvantages to this strategy. Thus, the clinician's recommendations must carefully balance the patient's preferences with what is known about cross-reactivity among foods. The severity of the patient's reaction, age of the patient, and nutritional needs also influence the decision. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical scenarios'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We advise patients with peanut, tree nut, or sesame allergy to avoid eating food from Asian (including Chinese and Thai) and Mexican restaurants, bakeries, and ice cream parlors, because peanut, tree nuts, and sesame are commonly used in these types of establishments. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Avoidance'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=see_link\">",
"       \"Management of food allergy: Avoidance\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients should be educated in the proper management of accidental exposures (",
"      <a class=\"graphic graphic_form graphicRef60439 \" href=\"mobipreview.htm?2/42/2722\">",
"       form 1",
"      </a>",
"      ). We prescribe",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      autoinjectors for all patients with a history of systemic reactions to peanut, tree nuts, or seeds. We also suggest prescribing epinephrine autoinjectors for all patients with milder IgE-mediated reactions to peanut, tree nuts, or seeds, especially if they have concomitant asthma, given the unpredictable nature of these food allergies (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Management of acute IgE-mediated reactions'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37430?source=see_link&amp;anchor=H16#H16\">",
"       \"Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Children should be periodically monitored for resolution of their food allergies, although it is very uncommon to outgrow allergy to peanut, tree nuts, and seeds beyond six years of age. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Monitoring for resolution'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H22#H22\">",
"       \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Natural history and prognosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/28/12746?source=see_link\">",
"       \"The natural history of childhood food allergy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recurrence of peanut allergy rarely may occur after a patient has passed an oral food challenge. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Recurrence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Siblings of children with peanut allergy are at higher risk than the general population of developing peanut allergy, especially if they show other signs of allergic disease such as atopic dermatitis. Thus, we suggest that atopic siblings be evaluated before peanut is introduced into their diet (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Management of younger siblings'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=see_link&amp;anchor=H12#H12\">",
"       \"Peanut, tree nut, and seed allergy: Clinical features\", section on 'Familial factors'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/37/25175?source=see_link&amp;anchor=H12#H12\">",
"       \"Introducing formula and solid foods to infants at risk for allergic disease\", section on 'Introduction of solid foods to high risk infants'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Several treatments are under investigation that may temporarily &ldquo;desensitize&rdquo; or provide long-term remission from food allergy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Future treatments'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44057?source=see_link\">",
"       \"Future therapies for food allergy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/1\">",
"      Pieretti MM, Chung D, Pacenza R, et al. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol 2009; 124:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/2\">",
"      Hefle SL, Furlong TJ, Niemann L, et al. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts. J Allergy Clin Immunol 2007; 120:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/3\">",
"      Wensing M, Penninks AH, Hefle SL, et al. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy. J Allergy Clin Immunol 2002; 110:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/4\">",
"      Peeters KA, Koppelman SJ, van Hoffen E, et al. Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy? Clin Exp Allergy 2007; 37:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/5\">",
"      Leung DY, Sampson HA, Yunginger JW, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/6\">",
"      Flinterman AE, Pasmans SG, Hoekstra MO, et al. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children. J Allergy Clin Immunol 2006; 117:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/7\">",
"      Kilburn SA, Nordlee JA, Hefle SL, et al. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol 1997; 100:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/8\">",
"      Ferdman RM, Church JA. Mixed-up nuts: identification of peanuts and tree nuts by children. Ann Allergy Asthma Immunol 2006; 97:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/9\">",
"      Fleischer DM, Conover-Walker MK, Christie L, et al. Peanut allergy: recurrence and its management. J Allergy Clin Immunol 2004; 114:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/10\">",
"      Ball H, Luyt D, Bravin K, Kirk K. Single nut or total nut avoidance in nut allergic children: outcome of nut challenges to guide exclusion diets. Pediatr Allergy Immunol 2011; 22:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/11\">",
"      Savage JH, Limb SL, Brereton NH, Wood RA. The natural history of peanut allergy: Extending our knowledge beyond childhood. J Allergy Clin Immunol 2007; 120:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/12\">",
"      Kagan R, Hayami D, Joseph L, et al. The predictive value of a positive prick skin test to peanut in atopic, peanut-na&iuml;ve children. Ann Allergy Asthma Immunol 2003; 90:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/13\">",
"      Johannsen H, Nolan R, Pascoe EM, et al. Skin prick testing and peanut-specific IgE can predict peanut challenge outcomes in preschoolchildren with peanut sensitization. Clin Exp Allergy 2011; 41:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/14\">",
"      Sicherer SH, Furlong TJ, Mu&ntilde;oz-Furlong A, et al. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001; 108:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/15\">",
"      Chiang WC, Pons L, Kidon MI, et al. Serological and clinical characteristics of children with peanut sensitization in an Asian community. Pediatr Allergy Immunol 2010; 21:e429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/16\">",
"      David TJ. Anaphylactic shock during elimination diets for severe atopic eczema. Arch Dis Child 1984; 59:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/17\">",
"      Ito K, Morishita M, Ito A, et al. [Immediate type food hypersensitivity associated with atopic dermatitis in children]. Arerugi 2004; 53:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/18\">",
"      Eller E, Kjaer HF, H&oslash;st A, et al. Food allergy and food sensitization in early childhood: results from the DARC cohort. Allergy 2009; 64:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/19\">",
"      Sampson HA, Mu&ntilde;oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/20\">",
"      Busse PJ, Nowak-Wegrzyn AH, Noone SA, et al. Recurrent peanut allergy. N Engl J Med 2002; 347:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32919/abstract/21\">",
"      Boyle RJ, Tang ML. Recurrent peanut allergy may not be prevented by continued peanut ingestion. Int Arch Allergy Immunol 2008; 147:260.",
"     </a>",
"    </li>",
"    <li>",
"     Sampson HA, 2009, unpublished observation.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2392 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-89.32.226.102-BE3A184D40-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32919=[""].join("\n");
var outline_f32_9_32919=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIETARY RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Avoidance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical scenarios",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MANAGEMENT OF ACUTE IgE-MEDIATED REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MONITORING FOR RESOLUTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MANAGEMENT OF YOUNGER SIBLINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      FUTURE TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2392\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2392|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"mobipreview.htm?2/42/2722\" title=\"form 1\">",
"      Anaphylaxis action plan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2392|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?31/41/32412\" title=\"table 1\">",
"      Ingredient label terms for peanut",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/13/221\" title=\"table 2\">",
"      Ingredient label terms for tree nut",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/47/36604\" title=\"table 3\">",
"      Ingredient label terms for sesame",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/13/1241?source=related_link\">",
"      Fatal anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/63/2042?source=related_link\">",
"      Food allergens: Overview of clinical features and cross-reactivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/39/3705?source=related_link\">",
"      Food allergy in schools and camps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/0/38920?source=related_link\">",
"      Food-induced anaphylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44057?source=related_link\">",
"      Future therapies for food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/37/25175?source=related_link\">",
"      Introducing formula and solid foods to infants at risk for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37430?source=related_link\">",
"      Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/59/20409?source=related_link\">",
"      Oral food challenges for diagnosis and management of food allergies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/42/43689?source=related_link\">",
"      Pathogenesis of food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/47/29429?source=related_link\">",
"      Patient information: Food allergy symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/35/35379?source=related_link\">",
"      Patient information: Food allergy treatment and avoidance (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/35/17971?source=related_link\">",
"      Patient information: Peanut allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/35/38457?source=related_link\">",
"      Peanut, tree nut, and seed allergy: Clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9654?source=related_link\">",
"      Peanut, tree nut, and seed allergy: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/28/12746?source=related_link\">",
"      The natural history of childhood food allergy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_9_32920="Syndromes of ketosis-prone diabetes mellitus";
var content_f32_9_32920=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Syndromes of ketosis-prone diabetes mellitus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32920/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32920/contributors\">",
"     Ashok Balasubramanyam, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32920/contributors\">",
"     Ramaswami Nalini, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32920/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32920/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/9/32920/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/9/32920/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/9/32920/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the mid-1990s increasing attention has been focused on a heterogeneous condition characterized by presentation with diabetic ketoacidosis (DKA) in patients who do not necessarily fit the typical characteristics of autoimmune type 1 diabetes. Earlier reports used the terms \"atypical diabetes,\" \"Flatbush diabetes,\" \"diabetes type 1B,\" and \"ketosis-prone type 2 diabetes mellitus\" to describe subsets of this condition, and it was noted that in some instances patients presented with DKA as the first manifestation of diabetes and evolved to insulin-independence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/1\">",
"     1",
"    </a>",
"    ]. While initially these reports suggested that the condition, now termed ketosis-prone diabetes (KPD), might be limited to persons of non-Caucasian ethnicity, its prevalence appears to be increasing worldwide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/2-22\">",
"     2-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The classification, pathophysiology, natural history, and management of KPD will be reviewed here. Patients with islet autoantibodies who do not present with ketosis, including those termed \"latent autoimmune diabetes in adults\" (LADA), \"type 1.5 diabetes\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/23,24\">",
"     23,24",
"    </a>",
"    ], and \"slowly progressing type 1 diabetes\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/25\">",
"     25",
"    </a>",
"    ] are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14874?source=see_link\">",
"     \"Classification of diabetes mellitus and genetic diabetic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF KPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ketosis prone diabetes (KPD) comprises a group of atypical diabetes syndromes characterized by severe beta cell dysfunction (manifested by presentation with DKA or unprovoked ketosis) and a variable clinical course. These syndromes do not fit the traditional categories of diabetes defined by the American Diabetes Association (ADA). To date, attempts to differentiate patients with KPD into clinically distinct subgroups have resulted in four different classification schemes: the ADA system, a modified ADA system, a BMI-based system, and the A&szlig; system. The goal of new classification schemes is to enable clinicians to predict which patients with DKA require temporary insulin treatment versus life-long insulin therapy. They also highlight subgroups for further genetic and pathogenetic studies.",
"   </p>",
"   <p>",
"    In a longitudinal study comparing the four classification schemes for accuracy and predictive value, the A&szlig; system was shown to be the most accurate in predicting long-term insulin dependence 12 months after the index DKA event, with 99 percent sensitivity and 96 percent specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/4,26\">",
"     4,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     ADA system",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the ADA classification, type 1 diabetes is characterized by autoimmune destruction of the pancreatic beta cells, leading to absolute insulin deficiency. Markers of immune-mediated diabetes include antibodies to glutamic acid decarboxylase (GAD) and to the tyrosine phosphatase IA-2. Among patients presenting with DKA (absolute insulin deficiency), those who lack autoantibodies are referred to as \"idiopathic type 1\" or \"type 1b\"; the latter includes patients with the clinical appearance of type 2 diabetes, with some becoming insulin-independent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14874?source=see_link&amp;anchor=H2#H2\">",
"     \"Classification of diabetes mellitus and genetic diabetic syndromes\", section on 'Type 1 diabetes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Modified ADA system",
"    </span>",
"    &nbsp;&mdash;&nbsp;A modification of the ADA scheme is utilized by investigators in France, who divide KPD patients into three groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/22\">",
"     22",
"    </a>",
"    ]. Patients with beta cell autoantibodies are classified as type 1a just as in the ADA scheme, while those who lack autoantibodies are distinguished retrospectively, based on long-term insulin dependence, into \"KPD insulin dependent\" (KPD-ID) and \"KPD non-insulin dependent\" (KPD-NID). Both type 1a and KPD-ID patients have clinical characteristics of type 1 diabetes with poor beta cell function, while subjects with KPD-NID have clinical characteristics of type 2 diabetes with preserved beta cell function for a prolonged duration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     BMI system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The BMI-based scheme separates KPD patients into lean (BMI &lt;28",
"    <span class=\"nowrap\">",
"     kg/m2,",
"    </span>",
"    clinically resembling type 1 with low beta cell function) or obese (BMI &ge;28",
"    <span class=\"nowrap\">",
"     kg/m2,",
"    </span>",
"    clinically resembling type 2 with preserved beta cell function) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     A&szlig; system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The collaborative group at Baylor College of Medicine and the University of Washington utilize a classification system (A&szlig; classification) that distinguishes four KPD subgroups based on the presence or absence of autoantibodies and the presence or absence of beta cell functional reserve, as measured by a fasting or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=see_link\">",
"     glucagon",
"    </a>",
"    -stimulated C-peptide level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Beta cell secretory reserve'",
"    </a>",
"    below.) The four subgroups are defined as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A+&szlig;- autoantibodies present, beta cell function absent",
"     </li>",
"     <li>",
"      A+&szlig;+ autoantibodies present, beta-cell function present",
"     </li>",
"     <li>",
"      A-&szlig;- autoantibodies absent, beta cell function absent",
"     </li>",
"     <li>",
"      A-&szlig;+ autoantibodies absent, beta cell function present",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A+&szlig;- and A-&szlig;- patients are immunologically and genetically distinct from each other but share clinical characteristics of type 1 diabetes with decreased beta cell function, and both subgroups would be termed type 1 diabetes (type 1 and 1b) in the current ADA classification system. A+&szlig;+ and A-&szlig;+ patients are immunologically and genetically distinct from each other but share clinical characteristics of type 2 diabetes with preserved beta cell functional reserve and would be termed type 2 diabetes in the ADA scheme.",
"   </p>",
"   <p>",
"    A-&szlig;+ patients comprise the largest KPD subgroup (approximately 50 percent) in multiethnic cohorts of KPD patients in the United States (",
"    <a class=\"graphic graphic_table graphicRef72722 \" href=\"mobipreview.htm?16/30/16878\">",
"     table 1",
"    </a>",
"    ). They are also the patients who most commonly come to the notice of clinicians because they present with DKA yet have the clinical features and subsequent behavior of type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/1,3,27\">",
"     1,3,27",
"    </a>",
"    ]. In the interest of defining and investigating novel syndromes of beta cell dysfunction, the broader terminology of \"ketosis-prone diabetes\" with its four subgroups subsumed under the A&szlig; classification, rather than ketosis-prone type 2 diabetes, is more useful and it does not presume to define a syndrome a priori.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY OF KPD SYNDROMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Autoantibodies present, beta cell function absent or present",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a spectrum of beta cell destruction in patients with antibody positive diabetes. Distinguishing A+&szlig;- from A+&szlig;+ KPD permits investigators to explore different autoimmune pathways leading to clinically distinct patterns of beta cell loss, such as different latencies and variable degrees of beta cell destruction.",
"   </p>",
"   <p>",
"    The later onset and more moderate clinical course (ability to discontinue insulin for over two years following the index episode of DKA in 50 percent of the patients) of A+&szlig;+ KPD compared to A+&szlig;- KPD appears to be related in part to epitope-specific antibodies to the 65-kDa isoform of glutamic acid decarboxylase (GAD65). A specific amino-terminal epitope defined by monoclonal antibody DPD correlated with higher beta cell functional reserve and was associated with the milder A+&szlig;+ phenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/28\">",
"     28",
"    </a>",
"    ]. The mechanisms that result in this autoantibody specificity and give rise to variable beta cell functional reserve remain to be elucidated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Autoantibodies and beta cell function absent",
"    </span>",
"    &nbsp;&mdash;&nbsp;A-&szlig;- KPD is characterized by beta cell failure without evidence of autoimmunity. Some A-&szlig;- KPD patients may possess untested autoantibodies such as those against the zinc transporter (ZnT8) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/29\">",
"     29",
"    </a>",
"    ] or SOX13 (SRY-related HMG box antigen 13) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/30\">",
"     30",
"    </a>",
"    ]. Alternatively, some A-&szlig;- KPD patients may be misclassified as \"A-\" because of a decline in autoantibody titers over time. In one cohort, only 10 percent of patients who were A-&szlig;- had new-onset diabetes when identified at presentation with DKA; the majority had had insulin-dependent diabetes for many years previously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, a decline in antibody titer is less likely as GAD autoantibodies are reported to be quite durable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. In addition, extensive HLA typing reveals that the frequencies of major class II alleles associated with susceptibility to autoimmune type 1 diabetes are not significantly higher in A-&szlig;- KPD patients than in ethnic-matched population controls, whereas they are significantly higher in A+&szlig;- KPD patients, suggesting significant differences in the two populations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The strong family history of diabetes in relatives of A-&szlig;- KPD suggests that there is a familial trait and that genes required for beta cell development, regeneration, or function may be involved. Potentially significant variants in the genes TCF1, PAX-4, and PDX-1, encoding the key beta cell transcription factors hepatocyte nuclear factor-1alpha (HNF1a), PAX-4, and pancreas-duodenum homeobox-1 (PDX-1), are enriched in A-&szlig;- KPD patients compared to ethnic-specific population controls; these may contribute to the A-&szlig;- phenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Autoantibodies absent, beta cell function present",
"    </span>",
"    &nbsp;&mdash;&nbsp;The A-&szlig;+ phenotype is characterized by partially reversible beta cell dysfunction, which may be due to metabolic, genetic, or viral etiologies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. Increased oxidant stress in the islets may also contribute to A-&szlig;+ KPD. In one study of West African patients, X-linked glucose-6-phosphate dehydrogenase (G6PD) deficiency contributed to depressed beta cell defense against oxidant stress in the face of acute hyperglycemia, but its cause does not appear to be a genetic mutation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY OF KPD SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of KPD after the initial episode of DKA depends upon the presence of autoantibodies and long-term beta cell reserve. Long-term beta cell reserve is the key determinant of long-term glycemic control and insulin dependence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The natural history of KPD is best detailed in large cohorts with longitudinal follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/2,10,11,22,34\">",
"     2,10,11,22,34",
"    </a>",
"    ]. One of the largest of these cohorts, the Houston cohort, includes 185 multiethnic adults patients admitted with DKA between 1999 and 2001 and followed for a mean of 5.5 years. The most frequent KPD subgroup was A-&szlig;+ (54 percent), followed by A-&szlig;-, A+&szlig;-, and A+&szlig;+ accounting for 20, 18, and 8 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The A+&szlig;- and A-&szlig;- KPD patients displayed a typical course of complete insulin dependence and difficulty in attaining and achieving excellent long-term glycemic control. Although there was no difference in the mean age of the patients admitted with DKA during study recruitment, there were significant group differences in mean age at diabetes diagnosis and duration of diabetes (",
"    <a class=\"graphic graphic_table graphicRef72722 \" href=\"mobipreview.htm?16/30/16878\">",
"     table 1",
"    </a>",
"    ). Compared to patients with the A-&szlig;+ and A+&szlig;+ phenotypes, patients with the A+&szlig;- and A-&szlig;- phenotypes were diagnosed at an earlier age (approximately 25 versus 40 years) and had a longer duration of diabetes (approximately nine versus two years).",
"   </p>",
"   <p>",
"    The majority of A+&szlig;+ KPD patients had new onset diabetes. Shortly after resolution of DKA, about 50 percent of patients had adequate beta cell functional reserve and could discontinue insulin; the others remain insulin dependent (",
"    <a class=\"graphic graphic_table graphicRef72722 \" href=\"mobipreview.htm?16/30/16878\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Approximately 50 percent of A-&szlig;+ KPD patients had new-onset diabetes and developed DKA without a clinically evident precipitating factor (\"unprovoked\" A-&szlig;+ KPD), while the remainder had had long-standing diabetes prior to presentation with DKA, and developed ketoacidosis in association with acute illness or noncompliance with antidiabetic treatment (\"provoked\" A-&szlig;+ KPD). Unprovoked A-&szlig;+ KPD patients displayed a striking male predominance (2.6:1, male:female) that is quite distinct from provoked A-&szlig;+ KPD patients (0.7:1); this gender imbalance has been noted also in patients with the unprovoked A-&szlig;+ KPD phenotype in other cohorts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/10,22,42\">",
"     10,22,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Longitudinal data suggest other phenotypic differences between the unprovoked and provoked subgroups of A-&szlig;+ KPD patients. Prospective assessment of 83 unprovoked and 64 provoked A-&szlig;+ KPD patients revealed that despite equivalent degrees of hyperglycemia and beta cell functional reserve at initial testing following the index DKA episode, the two subgroups had different genetic characteristics, natural histories of beta cell function, and insulin requirements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/43\">",
"     43",
"    </a>",
"    ]. Unprovoked A-&szlig;+ KPD was characterized by reversible beta-cell dysfunction with male predominance and increased frequency of DQB1*0602, whereas provoked A-&szlig;+ KPD was characterized by progressive loss of beta-cell reserve and increased frequency of DQB1*0302 and DRB1*04. In this prospective assessment, unprovoked DKA predicted long-term beta-cell functional reserve, insulin independence, and glycemic control in KPD patients.",
"   </p>",
"   <p>",
"    In a smaller cohort study of patients with new-onset unprovoked DKA, beta cell functional reserve was preserved in a greater proportion of obese compared with lean patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another cohort study with 10-year follow-up, KPD patients with the probable A-&szlig;+ phenotype (unprovoked) initially achieved insulin independence and glycemic control with oral agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/22\">",
"     22",
"    </a>",
"    ]. At the end of the follow-up period, 40 percent were still insulin independent. In those that required insulin, the mean duration until relapse to insulin dependence was 40 months. Some of these patients experienced relapsing and remitting ketosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF KPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical management of KPD includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute management of DKA",
"     </li>",
"     <li>",
"      Outpatient management shortly after resolution of DKA, including classification of the patient according to KPD subgroup and evaluation of predictive factors",
"     </li>",
"     <li>",
"      Long-term management",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Initial treatment is the same as for patients with type 1 diabetes and ketoacidosis. However, the long term outcomes and insulin requirements of these patients are variable. In the Houston cohort described above, insulin was successfully discontinued after 12 months of treatment in 50 and 44 percent of patients in the A+&szlig;+ and A-&szlig;+ subgroups, respectively, whereas all patients in the &szlig;- subgroups remained insulin dependent (",
"    <a class=\"graphic graphic_table graphicRef72722 \" href=\"mobipreview.htm?16/30/16878\">",
"     table 1",
"    </a>",
"    ). Thus, a subset of patients will require long-term insulin therapy to prevent recurrent ketoacidosis.",
"   </p>",
"   <p>",
"    As these patients are heterogeneous and the \"type\" of diabetes is unclear at presentation, they should all be maintained on insulin initially. In addition, in some patients ketoacidosis may result from transient suppression of beta cell function due to an increased sensitivity to glucose toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/1\">",
"     1",
"    </a>",
"    ]. In these patients, insulin therapy is required until recovery from the effects of glucose toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Acute management of DKA",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients who present with DKA should be treated according to established principles of acute management of the metabolic decompensation. Standard inpatient hospital protocols requiring aggressive fluid replacement, continuous insulin therapy, assessment for and treatment of precipitating factors, monitoring for resolution of hyperglycemia, ketoacidosis and electrolyte disorders, and transition from intravenous insulin to subcutaneous insulin regimens have been well-described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/48/15114?source=see_link\">",
"     \"Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Inpatient treatment during the episode of DKA should be the same regardless of the apparent phenotype of the KPD patient, and all KPD patients should be discharged from the hospital on a regimen that provides 24-hour insulin coverage. Any attempt to withdraw insulin treatment should be based upon precise classification of the KPD subgroup and assessment of predictive factors, which should be performed at the first outpatient visit one to three weeks following hospital discharge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Evaluation in the first 2 to 10 weeks following resolution of DKA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of beta cell secretory reserve and beta cell autoimmunity can be performed one to three weeks after resolution of ketoacidosis to minimize the acute effects of glucose toxicity or desensitization on beta cell function. Beta cell secretory reserve (as measured by fasting plasma C-peptide, C-peptide response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=see_link\">",
"     glucagon",
"    </a>",
"    stimulation, and C-peptide to glucose ratio) following DKA resolution is the strongest predictor of long-term glycemic control and insulin dependence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/40,41,44\">",
"     40,41,44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Beta cell secretory reserve",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta cell function can be assessed by measuring fasting or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=see_link\">",
"     glucagon",
"    </a>",
"    -stimulated C peptide concentrations. These tests are performed after an overnight fast and at least 10 hours after the last dose of short-acting or intermediate-acting insulin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    , or thiazolidinedione, and at least 24 hours after a dose of sulfonylurea or long-acting insulin (glargine, detemir) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/3\">",
"     3",
"    </a>",
"    ]. The fasting C-peptide measurement is less expensive and easier to perform.",
"   </p>",
"   <p>",
"    Patients are classified as \"&szlig;-\" if the fasting serum C peptide concentration is less than 1",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (0.33",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    and the peak serum C peptide response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=see_link\">",
"     glucagon",
"    </a>",
"    (measured at 5 and 10 minutes after intravenous injection of 1 mg glucagon) is less than 1.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (0.5",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/3\">",
"     3",
"    </a>",
"    ]. They are classified as \"&szlig;+\" if the fasting serum C peptide concentration is at least 1",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (0.33",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    or the peak serum C peptide response to glucagon is at least 1.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (0.5",
"    <span class=\"nowrap\">",
"     nmol/L).",
"    </span>",
"    Although the cut-points noted above do not independently predict the potential for successful and safe withdrawal of insulin, a high ratio (&gt;11) of fasting C-peptide (in",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    to glucose (in",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    at six months predicts such a course among &szlig;+ patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These cutpoints (established using the Linco RIA for human C-peptide) have been shown to accurately predict beta cell function and glycemic control after one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/4,40\">",
"     4,40",
"    </a>",
"    ]; however, they have not as yet been standardized across other C-peptide assays.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Beta cell autoimmunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although beta cell functional reserve provides most of the information required to predict the patient's clinical course, careful quantitative assessment of beta cell autoantibodies is also clinically useful, specifically for patients with the predominantly \"new-onset\" A+&szlig;+ KPD phenotype. Patients of this subgroup follow one of two divergent clinical courses within the first two years of diagnosis; approximately 50 percent maintain stable beta cell function and remain insulin independent, while the others convert to &szlig;- status and become insulin dependent. Hence identification of patients as A+&szlig;+ rather than simply &szlig;+ alerts the clinician to follow them closely. Furthermore, these are the patients in whom HLA genotyping provides additional prognostic markers of clinical behavior, as the presence of specific autoimmune type 1 diabetes susceptibility alleles such as HLA DQB1*02 are associated with higher risk of progressive beta cell functional loss. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/42/23210?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis of type 1 diabetes mellitus\", section on 'Genetic susceptibility'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    GAD65 and insulinoma-associated protein 2 (IA-2) autoantibody titers can be measured in the patients' sera by highly sensitive and specific assays, with care taken to establish the upper limits of the normal range for the autoantibody levels specifically for each regional ethnic group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients may be classified as \"A+\" if the autoantibody index for either of the autoantibodies exceeds the ethnic-specific 99",
"    <sup>",
"     th",
"    </sup>",
"    percentile or \"A-\" if the indices for both are below the 99",
"    <sup>",
"     th",
"    </sup>",
"    percentile.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Clinical practice",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term management of KPD can be guided rationally by accurate classification based upon assessment of beta cell functional reserve, beta cell autoantibodies, and in some instances, HLA allelotyping. Although assessment of these parameters in all patients presenting with DKA is ideal, cost constraints and assay availability may be prohibitive in some regions.",
"   </p>",
"   <p>",
"    For patients with DKA and the typical type 1 diabetes clinical phenotype (young, thin), it is probably unnecessary to check C-peptide or antibodies. These patients should be continued on insulin indefinitely.",
"   </p>",
"   <p>",
"    However, for anyone presenting in an atypical fashion (older, overweight, no spontaneous weight loss, non-Caucasian ethnicity), measurement of C-peptide and antibodies (GAD65, IA-2) should be considered for classification of KPD type and for greater certainty in selecting patients for insulin withdrawal. In regions where such testing is unavailable, future likelihood of insulin independence in atypically presenting patients can be assessed by reducing the insulin dose and monitoring serum glucose and serum or urine ketones. The safety of the latter approach depends upon a patient's ability to self-monitor and the attentiveness of the provider. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Assessing for insulin independence'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Glycemic management in the first 2 to 10 weeks following discharge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the \"type\" of diabetes is unclear at presentation, all patients should be maintained on insulin initially. Insulin should never be discontinued in patients who are classified as \"&szlig;-\", regardless of whether they are A+ or A-, as these patients invariably require insulin to avoid ketosis. Evidence from the Houston cohort shows that no patient initially classified as \"&szlig;-\" by the above protocol has recovered beta cell function sufficiently to warrant a trial of insulin withdrawal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Assessing for insulin independence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Future likelihood of insulin independence in patients who are initially categorized as \"&szlig;+\" may be assessed as follows. Patients are placed on twice daily NPH insulin at the time of hospital discharge, with the dose determined by the mean daily insulin requirement during the previous two hospital days. Patients with known diabetes may be given insulin at the dose they were receiving before the onset of DKA. In previously insulin-naive patients, another approach is to administer multidose insulin at a dose of 0.6 to 0.8",
"    <span class=\"nowrap\">",
"     units/kg",
"    </span>",
"    per day, with 50 percent as regular or rapid-acting insulin (in divided doses before meals) and 50 percent as basal insulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Dose can be titrated with frequent glucose monitoring until an optimal dose is established. The first clinic visit is within two weeks of discharge from the hospital. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24906?source=see_link&amp;anchor=H11#H11\">",
"     \"Insulin therapy in adults with type 1 diabetes mellitus\", section on 'Designing an MDI insulin regimen'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If capillary blood glucose values before each meal and at bedtime during a two-week period attain ADA goals for",
"    <span class=\"nowrap\">",
"     fasting/pre-prandial",
"    </span>",
"    (90 to 130",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [5.0 to 7.2",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     bedtime/peak",
"    </span>",
"    post-prandial plasma glucose levels (180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [10.0",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    the insulin dose is reduced by 50 percent and the patient reassessed in the clinic one week later. If mean blood glucose values remain at goal for two consecutive clinic visits, insulin is discontinued and the patient is monitored closely.",
"   </p>",
"   <p>",
"    Patients are advised to use urine ketone strips or a blood ketone testing meter to check for significant ketosis if the blood glucose level rises above 200",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    If blood glucose values remain at goal, they are instructed to continue with lifestyle modification and are monitored without pharmacologic therapy.",
"   </p>",
"   <p>",
"    If blood glucose values increase without development of ketosis, the patients are placed on oral hypoglycemic agents. In A-&szlig;+ patients, insulin sensitizing agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    are recommended, as these patients have the highest frequency of the metabolic syndrome among KPD groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=see_link\">",
"     \"Initial management of blood glucose in type 2 diabetes mellitus\"",
"    </a>",
"    .) If blood glucose levels do not achieve therapeutic targets within eight weeks, addition of low doses of a sulfonylurea, thiazolidinedione, meglitinide or alpha-glucosidase inhibitor should be considered. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/19/28986?source=see_link\">",
"     \"Management of persistent hyperglycemia in type 2 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Aggressive management of the metabolic syndrome (including weight loss and exercise) and cardiovascular risks are important in all subgroups of KPD patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=see_link&amp;anchor=H16#H16\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\", section on 'Lifestyle modification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Conversely, if the patient develops ketosis upon decreasing the insulin dose, the insulin regimen is intensified and no further attempts are made to discontinue insulin. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24906?source=see_link\">",
"     \"Insulin therapy in adults with type 1 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The duration of this process of insulin withdrawal is variable and may range from 10 to 14 weeks to longer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Long-term management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the patient has been classified for KPD type, assessed for predictive factors and begun on an appropriate treatment course, standards of diabetes management should be followed. Patients should be counseled by a nutritionist and diabetic educator periodically. Physical activity for at least 150 minutes per week should be recommended, and weight loss may be advised for all obese patients. Smoking cessation should be reinforced. Screening and treatment for microvascular and macrovascular complications of diabetes are advised. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/38/36458?source=see_link\">",
"     \"Overview of medical care in adults with diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Special considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;As described earlier, A-&szlig;+ KPD patients may be divided into a new-onset \"unprovoked\" group (presenting with DKA in the absence of significant stress) and a previously diagnosed \"provoked\" group (DKA associated with significant stress). Patients in the former subgroup have a significantly greater rate of insulin discontinuation and better long-term glycemic control than the latter.",
"   </p>",
"   <p>",
"    New onset diabetes, older age at onset of diabetes, and high levels of beta cell functional reserve (fasting C-peptide to glucose ratio &gt;11) may be used as reliable predictors of insulin discontinuation in &szlig;+ patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/41,44,48,49\">",
"     41,44,48,49",
"    </a>",
"    ]. In a multivariate model, new onset diabetes and beta cell functional reserve remained predictive.",
"   </p>",
"   <p>",
"    The presence of beta cell autoantibodies is a determinant of future beta cell function. In analyses that do not differentiate the four A&szlig; subgroups, KPD patients with autoantibodies tend to have lower beta cell function both shortly after the correction of the acidosis and on long-term follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/9/32920/abstract/17,22\">",
"     17,22",
"    </a>",
"    ]. However, this is not an infallible criterion, as approximately 50 percent of A+&szlig;+ KPD patients maintain long-term beta cell functional reserve. Most A+&szlig;+ KPD patients are able to come off insulin therapy initially, but they require close monitoring for at least two years, since the evolution of their beta cell function is the least predictable of the KPD groups. HLA typing may play a useful role in the management of this group of KPD patients, as it may help to identify those who are likely to experience a more aggressive course or may be candidates for future immunomodulatory therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ketosis-prone diabetes (KPD) is a heterogeneous syndrome characterized by the presence of diabetic ketoacidosis in patients who may lack the typical clinical phenotype of autoimmune type 1 diabetes. Recognition of KPD coincides with the emergence of the concept that early beta cell dysfunction is likely to be a primary defect in the pathophysiology of diabetes, regardless of \"type.\" Although proper epidemiologic surveys remain to be conducted, syndromes of KPD appear to be increasingly recognized worldwide, especially among urban, multiethnic populations. They offer challenges to both clinicians and researchers, but also offer the prospect of revealing novel mechanisms of beta cell dysfunction relevant to common forms of diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Classification",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are four different classification schemes for KPD. The A&szlig; classification distinguishes four KPD subtypes based upon the presence or absence of autoantibodies and beta cell functional reserve. This classification most accurately predicts long-term insulin dependence 12 months after DKA presentation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification of KPD'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Evaluation and management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      DKA should be treated according to established principles. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/48/15114?source=see_link\">",
"       \"Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      When patients are discharged from the hospital after resolution of DKA, we recommend initial treatment with insulin, rather than oral agents, regardless of the apparent phenotype of the KPD patient (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Management of KPD'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assessment of beta cell reserve and beta cell autoimmunity after resolution of DKA helps predict clinical course and long-term treatment. This assessment is typically performed one to three weeks after resolution of ketoacidosis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Evaluation in the first 2 to 10 weeks following resolution of DKA'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Natural history",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with poor beta cell function (&szlig;-) after resolution of the index DKA event typically require long-term exogenous insulin therapy, regardless of autoantibody status. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Glycemic management in the first 2 to 10 weeks following discharge'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with beta cell secretory reserve who are antibody negative (A-&szlig;+) are often able to discontinue insulin, especially if they had unprovoked DKA as the initial manifestation of diabetes. The duration of the process of insulin withdrawal is variable and may range from 10 to 14 weeks to longer. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Assessing for insulin independence'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      If after discontinuation of insulin blood glucose values increase without development of ketosis, treatment with oral or injectable agents to lower blood glucose is required.",
"      <br/>",
"      <br/>",
"      If the patient develops ketosis upon decreasing the insulin dose, insulin should be intensified. In this setting, we suggest not attempting to withdraw insulin a second time (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Assessing for insulin independence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with preserved beta cell function who have autoantibodies (A+&szlig;+) have a variable course with some demonstrating progressive beta cell deterioration and others long-term preservation. This group of individuals requires more careful monitoring, and these patients may benefit from HLA genotyping to provide additional prognostic markers of clinical behavior. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Beta cell autoimmunity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/1\">",
"      Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 2006; 144:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/2\">",
"      Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev 2008; 29:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/3\">",
"      Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 2003; 88:5090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/4\">",
"      Balasubramanyam A, Garza G, Rodriguez L, et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care 2006; 29:2575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/5\">",
"      Dodu SR. Diabetes in the tropics. Br Med J 1967; 2:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/6\">",
"      Adadevoh BK. \"Temporary diabetes\" in adult Nigerians. Trans R Soc Trop Med Hyg 1968; 62:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/7\">",
"      Oli JM. Remittant diabetes mellitus in Nigeria. Trop Geogr Med 1978; 30:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/8\">",
"      Winter WE, Maclaren NK, Riley WJ, et al. Maturity-onset diabetes of youth in black Americans. N Engl J Med 1987; 316:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/9\">",
"      Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994; 43:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/10\">",
"      Umpierrez GE, Casals MM, Gebhart SP, et al. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/11\">",
"      Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 1999; 22:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/12\">",
"      Aizawa T, Katakura M, Taguchi N, et al. Ketoacidosis-onset noninsulin dependent diabetes in Japanese subjects. Am J Med Sci 1995; 310:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/13\">",
"      Wilson C, Krakoff J, Gohdes D. Ketoacidosis in Apache Indians with non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157:2098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/14\">",
"      Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997; 20:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/15\">",
"      Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999; 159:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/16\">",
"      Westphal SA. The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults. Am J Med 1996; 101:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/17\">",
"      Pi&ntilde;ero-Pilo&ntilde;a A, Litonjua P, Aviles-Santa L, Raskin P. Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care 2001; 24:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/18\">",
"      Pitteloud N, Philippe J. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr 2000; 130:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/19\">",
"      Jabbar A, Farooqui K, Habib A, et al. Clinical characteristics and outcomes of diabetic ketoacidosis in Pakistani adults with Type 2 diabetes mellitus. Diabet Med 2004; 21:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/20\">",
"      Tan KC, Mackay IR, Zimmet PZ, et al. Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care 2000; 23:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/21\">",
"      Sobngwi E, Mauvais-Jarvis F, Vexiau P, et al. Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabetes Metab 2002; 28:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/22\">",
"      Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004; 53:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/23\">",
"      Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, et al. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 2000; 49:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/24\">",
"      Naik RG, Palmer JP. Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord 2003; 4:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/25\">",
"      Kobayashi T. Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM--the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 1994; 24 Suppl:S95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/26\">",
"      Banerji MA, Dham S. A comparison of classification schemes for ketosis-prone diabetes. Nat Clin Pract Endocrinol Metab 2007; 3:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/27\">",
"      Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care 2006; 29:2755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/28\">",
"      Hampe CS, Nalini R, Maldonado MR, et al. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus. J Clin Endocrinol Metab 2007; 92:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/29\">",
"      Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007; 104:17040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/30\">",
"      Kasimiotis H, Fida S, Rowley MJ, et al. Antibodies to SOX13 (ICA12) are associated with type 1 diabetes. Autoimmunity 2001; 33:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/31\">",
"      Decochez K, Tits J, Coolens JL, et al. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care 2000; 23:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/32\">",
"      Borg H, Gotts&auml;ter A, Fernlund P, Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002; 51:1754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/33\">",
"      Rowley MJ, Mackay IR, Chen QY, et al. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/34\">",
"      Nalini R, Gaur LK, Maldonado M, et al. HLA class II alleles specify phenotypes of ketosis-prone diabetes. Diabetes Care 2008; 31:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/35\">",
"      Haaland WC, Scaduto DI, Maldonado MR, et al. A-beta-subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome. Diabetes Care 2009; 32:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/36\">",
"      Umpierrez GE, Smiley D, Gosmanov A, Thomason D. Ketosis-prone type 2 diabetes: effect of hyperglycemia on beta-cell function and skeletal muscle insulin signaling. Endocr Pract 2007; 13:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/37\">",
"      Mauvais-Jarvis F, Smith SB, Le May C, et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet 2004; 13:3151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/38\">",
"      Sobngwi E, Choukem SP, Agbalika F, et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans. JAMA 2008; 299:2770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/39\">",
"      Sobngwi E, Gautier JF, Kevorkian JP, et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. J Clin Endocrinol Metab 2005; 90:4446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/40\">",
"      Maldonado M, D'Amico S, Otiniano M, et al. Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis. Diabetes Obes Metab 2005; 7:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/41\">",
"      Maldonado MR, Otiniano ME, Cheema F, et al. Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function. Diabet Med 2005; 22:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/42\">",
"      Pi&ntilde;ero-Pilo&ntilde;a A, Raskin P. Idiopathic Type 1 diabetes. J Diabetes Complications 2001; 15:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/43\">",
"      Nalini R, Ozer K, Maldonado M, et al. Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of \"A-&beta;+\" ketosis-prone diabetes based on long-term &beta;-cell function, human leukocyte antigen class II alleles, and sex predilection. Metabolism 2010; 59:1448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/44\">",
"      Sobngwi E, Vexiau P, Levy V, et al. Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med 2002; 19:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/45\">",
"      Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007; 30:2181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/46\">",
"      Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2006; 29:2739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/47\">",
"      Otiniano ME, Balasubramanyam A, Maldonado M. Presence of the metabolic syndrome distinguishes patients with ketosis-prone diabetes who have a Type 2 diabetic phenotype. J Diabetes Complications 2005; 19:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/48\">",
"      Hsin Yu E, Guo HR, Wu TJ. Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients. Diabet Med 2001; 18:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/9/32920/abstract/49\">",
"      Rasouli N, Elbein SC. Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. J Clin Endocrinol Metab 2004; 89:6331.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1775 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-869C284B9E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32920=[""].join("\n");
var outline_f32_9_32920=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION OF KPD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ADA system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Modified ADA system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      BMI system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      A&szlig; system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOPHYSIOLOGY OF KPD SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Autoantibodies present, beta cell function absent or present",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Autoantibodies and beta cell function absent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Autoantibodies absent, beta cell function present",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      NATURAL HISTORY OF KPD SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      MANAGEMENT OF KPD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Acute management of DKA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Evaluation in the first 2 to 10 weeks following resolution of DKA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Beta cell secretory reserve",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Beta cell autoimmunity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Clinical practice",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Glycemic management in the first 2 to 10 weeks following discharge",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Assessing for insulin independence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Long-term management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Special considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Natural history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/1775\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/1775|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/30/16878\" title=\"table 1\">",
"      AB subgroups KPD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14874?source=related_link\">",
"      Classification of diabetes mellitus and genetic diabetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/35/43577?source=related_link\">",
"      Initial management of blood glucose in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/20/24906?source=related_link\">",
"      Insulin therapy in adults with type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/19/28986?source=related_link\">",
"      Management of persistent hyperglycemia in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/38/36458?source=related_link\">",
"      Overview of medical care in adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/42/23210?source=related_link\">",
"      Pathogenesis of type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/48/15114?source=related_link\">",
"      Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_9_32921="Acne keloidalis nuchae on posterior scalp";
var content_f32_9_32921=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87490&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87490&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Acne keloidalis nuchae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dome-shaped, firm papules are present on the posterior scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32921=[""].join("\n");
var outline_f32_9_32921=null;
var title_f32_9_32922="Dermatofibroma - dark skin";
var content_f32_9_32922=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68729%7EDERM%2F80587%7EDERM%2F80575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68729%7EDERM%2F80587%7EDERM%2F80575&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatofibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This oval, hyperpigmented, firm papule is a dermatofibroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatofibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This firm, hyperpigmented papule on the shin is a dermatofibroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatofibroma \"dimple sign\"",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A \"dimple\" is elicited on compression of this dermatofibroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32922=[""].join("\n");
var outline_f32_9_32922=null;
var title_f32_9_32923="Indications laparoscop liver bx";
var content_f32_9_32923=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for and contraindications to laparoscopic liver biopsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Same as for percutaneous liver biopsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        When a liver biopsy is needed in the presence of ascites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        When a laparoscopy is needed for:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         A. Staging of malignancy",
"        </p>",
"        <p>",
"         B. Diagnosis of peritoneal infections (like tuberculosis)",
"        </p>",
"        <p>",
"         C. Evaluation of abdominal mass",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Contraindications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Absolute:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Severe cardiopulmonary failure",
"         </li>",
"         <li>",
"          Bowel obstruction",
"         </li>",
"         <li>",
"          Spontaneous or secondary bacterial peritonitis",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Relative:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ul>",
"         <li>",
"          Uncooperative patient",
"         </li>",
"         <li>",
"          Significant coagulopathy or thrombocytopenia",
"         </li>",
"         <li>",
"          Morbid obesity",
"         </li>",
"         <li>",
"          Large ventral hernia",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344:499.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32923=[""].join("\n");
var outline_f32_9_32923=null;
var title_f32_9_32924="Burn class chart";
var content_f32_9_32924=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F50237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F50237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified Lund-Browder chart for assessing percent total body surface area burn in children and adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Area*",
"      </td>",
"      <td class=\"subtitle1\">",
"       Birth to 1 year",
"      </td>",
"      <td class=\"subtitle1\">",
"       1 to 4 years",
"      </td>",
"      <td class=\"subtitle1\">",
"       5 to 9 years",
"      </td>",
"      <td class=\"subtitle1\">",
"       10 to 14 years",
"      </td>",
"      <td class=\"subtitle1\">",
"       Adult",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Head",
"      </td>",
"      <td>",
"       9.5",
"      </td>",
"      <td>",
"       8.5",
"      </td>",
"      <td>",
"       6.5",
"      </td>",
"      <td>",
"       5.5",
"      </td>",
"      <td>",
"       4.5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neck",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Trunk",
"      </td>",
"      <td>",
"       13",
"      </td>",
"      <td>",
"       13",
"      </td>",
"      <td>",
"       13",
"      </td>",
"      <td>",
"       13",
"      </td>",
"      <td>",
"       13",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Upper arm",
"      </td>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Forearm",
"      </td>",
"      <td>",
"       1.5",
"      </td>",
"      <td>",
"       1.5",
"      </td>",
"      <td>",
"       1.5",
"      </td>",
"      <td>",
"       1.5",
"      </td>",
"      <td>",
"       1.5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hand",
"      </td>",
"      <td>",
"       1.25",
"      </td>",
"      <td>",
"       1.25",
"      </td>",
"      <td>",
"       1.25",
"      </td>",
"      <td>",
"       1.25",
"      </td>",
"      <td>",
"       1.25",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Thigh",
"      </td>",
"      <td>",
"       2.75",
"      </td>",
"      <td>",
"       3.25",
"      </td>",
"      <td>",
"       4",
"      </td>",
"      <td>",
"       4.25",
"      </td>",
"      <td>",
"       4.5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Leg",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       3",
"      </td>",
"      <td>",
"       3.25",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Foot",
"      </td>",
"      <td>",
"       1.75",
"      </td>",
"      <td>",
"       1.75",
"      </td>",
"      <td>",
"       1.75",
"      </td>",
"      <td>",
"       1.75",
"      </td>",
"      <td>",
"       1.75",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Buttock",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Genitalia",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Values listed are for one surface area and each individual extremity. Anterior and posterior surface area values are equivalent in estimating TBSA. For circumferential burns, multiply surface area burned by two.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32924=[""].join("\n");
var outline_f32_9_32924=null;
var title_f32_9_32925="Erythropoietin dose response";
var content_f32_9_32925=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F54593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F54593&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dose response of EPO-induced correction of uremic anemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 212px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Slope of the rate of increase in the hematocrit in patients on maintenance dialysis given various doses (15 to 500 units/kg) of erythropoietin (EPO) three times per week. The response is fastest at the highest dose, but a gradual and adequate rise in hematocrit is achieved in most patients with 50 units/kg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Eschbach, JW, Egrie, JC, Downing, MR, et al, N Engl J Med 1987; 316:73.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32925=[""].join("\n");
var outline_f32_9_32925=null;
var title_f32_9_32926="Measles vaccine exemptions";
var content_f32_9_32926=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 514px\">",
"   <div class=\"ttl\">",
"    US residents with measles who were eligible* for vaccination against measles, by reason for not receiving measles vaccine - United States, January-July 2008",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 494px; height: 313px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * N = 95. Does not include infants aged &lt;12 months, persons born before 1957, foreign visitors, and persons who were vaccinated.",
"     <br>",
"      &bull; Includes children aged 16 months to 4 years who had not been vaccinated.",
"      <br>",
"       &Delta; Includes persons who were age eligible for vaccination but whose vaccination status was unknown or who were unvaccinated for unknown reasons.",
"       <br>",
"        &loz; Includes eight children eligible for vaccination but not yet vaccinated, and one child whose vaccination status was unknown.",
"        <br>",
"         &sect; Includes persons who were unvaccinated because of their own or their parents' beliefs. This category includes 61 persons aged &le;18 years and two persons aged 20-50 years. None of the persons in this category cited medical reasons for not having been vaccinated.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Centers for Disease Control and prevention. Update: Measles - United States, January-July 2008. MMWR 2008; 57:895.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32926=[""].join("\n");
var outline_f32_9_32926=null;
var title_f32_9_32927="Lumbar hernia sup triangle";
var content_f32_9_32927=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F65959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F65959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lumbar hernia through the superior triangle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the multiple bony anomalies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eisenberg, RL. Clinical Imaging: An Atlas of Differential Diagnosis, Fourth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_9_32927=[""].join("\n");
var outline_f32_9_32927=null;
